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ABSTRACT OF THE DISSERTATION 
 
Modification of poly(L-Homoallylglycine)  
for the Synthesis of Functional Polypeptides 
 
by 
 
Pesach Perlin 
Doctor of Philosophy in Chemistry 
University of California, Los Angeles, 2019 
Professor Timothy J. Deming, Chair 
 
Synthetic polypeptides have demonstrated great potential for a variety of biomaterial 
applications due to their ability to self-assemble into ordered structures.  The ability to design 
polypeptides with a variety of functionalities is necessary for tailoring the solubility, 
conformational properties, and environmental responses of polypeptide-based materials.  Post 
polymerization modification of reactive residues has emerged as a desirable method for the 
design of functional polypeptides due to straightforward monomer synthesis and purification and 
the potential to synthesize a variety of functional polypeptides from a single reactive polypeptide 
precursor.  This dissertation describes the development and subsequent modification of poly(L-
homoallylglycine), a soluble, α-helical alkene bearing polypeptide.  
 L-Homoallylglycine N-carboxyanhydride monomers were synthesized and used to 
prepare poly(L-homoallylglycine) polypeptides with controllable lengths of up to 245 residues.  
These polypeptides were modified under mild conditions via UV initiated thiol-ene chemistry to 
give a variety of α-helical water soluble thioether containing polypeptides.   These derivatives 
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were able to undergo a conformational change from α-helix to random coil upon thioether 
oxidation or alkylation.  Incorporation of L-homoallylglycine residues into block copolypeptides 
with L-methionine residues allowed for the synthesis of block copolypeptides with separate 
ordered segments of sulfoxide residues and sulfonium residues. 
 The thiol-ene reactivity of poly(L-homoallylglycine) was then utilized to synthesize 
polypeptides containing N-methylaminooxy functionality.  The solubility, conformation, and 
reactivity of these poly(L-Homoallylglycine) derived polypeptides was compared to more 
hydrophilic N-methylaminooxy polypeptides synthesized via a functional monomer approach.   
The unique reactivity of N-methylaminooxy groups with non-protected reducing sugars 
facilitated the straightforward synthesis of glycopolypeptides which possessed good aqueous 
solubility and were stable at pH 7.4 for one week.  This post polymerization modification 
technique shows promise as a potential strategy for the synthesis of proteoglycan mimics. 
 The thiol-ene chemistry of poly(L-homoallylglycine) was proven to be highly versatile, but 
the resulting thiol-ene conjugates often have limited aqueous solubility due to their long 
hydrophobic side chains.  Therefore, poly(L-homoallylglycine) was oxidized to an epoxide 
bearing polypeptide, poly(5,6-epoxy-L-norleucine) and modified with thiols under basic 
conditions to synthesize a variety of β-hydroxy thioether containing polypeptides with 
considerably higher aqueous solubility than previously synthesized thiol-ene conjugates.  
Diethylene glycol thiol modified poly(5,6-epoxy-L-norleucine) derivatives displayed lower critical 
solution temperature properties in water that could be modulated by varying polypeptide 
concentration, polypeptide composition, and could be switched off through oxidation of their 
thioether groups. 
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Chapter 1: Functional Polypeptides: Synthesis and Applications 
1.1 Polypeptide Synthesis 
 Proteins and peptides play vital roles in every living organism.  These naturally occurring 
molecules are composed of various amino acids combined in unique and precise sequences.1  
They are involved in many physiological and biological processes including transport of 
substances through membranes, intracellular signaling, and playing a role in organisms’ 
immune system as antibodies.  Therefore, proteins and peptides have been of major interest to 
biologists and chemists alike for well over a century, inspiring a variety of biological and 
chemical methods to synthesize and isolate these macromolecules.2 
 Biological protein synthesis involves utilizing organisms’ cellular machinery to synthesize 
complex, monodisperse polypeptides and can be divided into two categories: cloning a DNA 
sequence from an organism which encodes a natural protein, and designing a DNA sequence to 
encode an originally designed amino acid sequence tailored for specific structure and function.3  
The DNA sequences are then inserted into cells in the form of plasmids, where proteins 
expressed and synthesized de novo from their amino acid monomers.4 
 Cloning naturally occurring DNA sequences has been utilized to synthesize enzymes 
which are useful for a variety of chemical processes5, as well as naturally occurring protein-
based materials.6  However, the scope of this method is restricted by what is readily available in 
nature.  Synthesis of non-natural proteins has been used to design proteins with discrete 
structural motifs, such as β-sheets7 and α-helices,8 allowing for complex protein structure 
activity relationship studies.9  This technique can also be applied to incorporate non-canonical 
amino acids into proteins which can then be subsequently chemically modified to modulate 
activity or label the protein for observation in vivo.10   
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Though recombinant DNA based synthetic techniques are useful for synthesizing highly 
complex polypeptides with precise sequence control, there are notable drawbacks to these 
methods.  If modifications to a sequence are required, a new gene must be synthesized.  
Biosynthesized proteins often require intensive purification protocols or modification of the 
amino acid sequence for purification via affinity chromatography.4  This methodology can also 
be intolerant of non-canonical amino acids, resulting in low yields.11   
Chemical polypeptide synthesis aims to avoid these pitfalls, though it is difficult to rival 
the length and structural complexity of biosynthesized proteins.4  The two most common 
chemical polypeptide synthesis methods are solid phase peptide synthesis (SSPS) and N-
carboxyanhydride (NCA) polymerization.12  Solid phase peptide synthesis (Figure 1.1) is a 
process involving immobilization of a growing peptide chain on a solid resin, stepwise addition 
of N-protected amino acid monomers through use of a coupling agent (current methods use 
triazoles such as HOBt or HBTU), and cleavage from the resin to release the synthesized 
polypeptide.13 
 
Figure 1.1 Solid-phase peptide synthesis.  Fmoc = fluorenylmethoxycarbonyl. 
 Though this method produces polypeptides with sequence control rivaling biosynthetic 
methods and is highly compatible with non-canonical amino acids, it is not practical for 
preparation of large polypeptides (100 residues or greater).12  Each residue addition requires at  
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least four steps, and additional protecting group considerations must be made for amino acids 
with reactive side chains.1  This process suffers from low atom economy and sequence defects 
due to incomplete coupling and deprotections steps.13  NCA polymerization is currently the most 
efficient method for synthesizing high molecular weight polypeptides.  This technique involves 
the ring opening polymerization of cyclic anhydride derivatives of amino acid to synthesize 
polypeptides (Figure 1.2).   
 
Figure 1.2 Ring-opening polymerization of NCA monomers. 
Benefits to NCA polymerization include the potential for high molecular weight, high atom 
economy, simple deprotection, and facile isolation.12  Though NCA polymerization does not 
have the same precision in sequence control of SPPS, current initiation methods allow for the 
synthesis of multiblock copolypeptides of defined size and sequence that give potential for 
highly precise structure and function.14 
1.2 NCA Polymerization 
 NCA polymerization has been the most common method for large scale preparation of 
high molecular weight polypeptides for over 70 years.15  Until the late 1990’s, materials 
synthesized through this procedure were primarily homopolymers, random copolymers, and 
other architectures which lacked the sequence specificity and low dispersity desirable for use in 
material applications.12, 14, 16  The limitations of NCA polymerization were due to initiation 
methods that gave poor control leading to deleterious side reactions.  However, the 
development of controlled NCA polymerization methods has allowed for the synthesis of high 
molecular weight polypeptides with low dispersity and high complexity that have facilitated the 
design of a variety of polypeptide-based materials.14, 17 
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 There are two common methods for the preparation of NCA’s: the Leuchs method and 
the Fuchs-Farthing method (Figure 1.3)18.  The Leuchs method involves cyclization of N-
alkoxycarbonyl amino acid halides.19  The acid halide is typically generated in situ via use of a 
halogenating agent such as PX3, PX5 (X = Cl, Br), dichloromethyl methyl ether, or Ghosez 
reagent.16, 20, 21  The Fuchs-Farthing method, on the other hand is used to synthesize an NCA 
directly from a free amino acid via treatment with phosgene.22, 23   
 
Figure 1.3 Common methods of NCA synthesis.  a) Leuchs method, X = Cl, Br.  b) Fuchs-
Farthing method.  
Due to the high volatility of phosgene, many later procedures use liquid diphosgene24 
and solid triphosgene.25  Though the Leuchs method typically leads to more impurities than the 
Fuchs-Farthing method, both synthetic methods can be used to produce pure NCAs after 
purification steps including precipitation, crystallization, or a recently developed purification 
method involving anhydrous column chromatography.26  Therefore, the method used should be 
chosen based on the desired NCA.  If synthesizing an NCA from a free amino acid, the Fuchs-
Farthing method is preferable.  However, some amino acids require protection of the alpha-
amino group during their synthesis, making the Leuchs method more convenient.27 
 The three most prominent methods of controlled NCA polymerization are amine-initiated, 
transition metal initiated, and silane initiated polymerizations.17  Though traditional amine-
initiated polymerizations showed poor control, techniques such as polymerization under 
vacuum28, and polymerization under low temperature29 were developed to reduce side 
reactions, allowing for good length control and low polydispersity.  The mechanism for this 
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process involves nucleophilic attack by the amine to open the ring and subsequent loss of CO2 
(Figure 1.4). 
 
Figure 1.4 Amine-initiated mechanism for NCA polymerization. 
 Transition metal initiation allows for living NCA polymerization with control of chain 
lengths and low dispersity at a considerably higher polymerization rate than controlled amine-
initiated polymerizations, allowing for facile synthesis of complex block copolypeptides.12  This 
method involves the use of electron-rich zerovalent complexes of Cobalt, Nickel, Iron, 
Ruthenium, or Platinum.30  The mechanism (Figure 1.5) begins with oxidative addition of the 
metal across the anhydride bond followed by subsequent loss of carbon monoxide.31 Addition of 
a second monomer unit followed by loss of CO2 then occurs to form a six-membered 
metallocycle.  The propagating species was found to be a five-membered amido-amidate 
metallocycle, which is formed by subsequent monomer addition followed by CO2 loss and 
proton migration.12  The zerovalent complex Co(PMe3)4 has been shown to be very reactive 
during initiation, giving good initiation and propagation rate for NCA polymerization.17 
 
Figure 1.5 Zerovalent metal-initiated mechanism for NCA polymerization. 
 A third distinct method for the ring opening polymerization of NCA monomers was 
developed utilizing hexamethyldisilazane (HMDS).32  Unlike traditional amines, HMDS allows for 
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controlled polymerization at room temperature and standard pressure.17  HMDS and similar N-
TMS amines are thought to open the NCA to yield a TMS-carbamate active chain-end12 that 
reduces side reactions in a similar fashion to group-transfer polymerization of vinyl monomers 
(Fig 1.6).33  These initiators can be used in a similar fashion as zerovalent metal initiators to 
synthesize block copolypeptides, but polymerize at a considerably slower rate.17 
 
Figure 1.6 N-TMS amine-initiated mechanism for NCA polymerization. 
 A notable difference between NCA polymerization and the other methods of polypeptide 
synthesis is the lack of precise sequence control.4  However, the controlled polymerization 
techniques discussed in this section allow for the synthesis of block copolypeptides with 
segments of controlled length.  This allows for regional control of polypeptide conformation and 
solubility, similar to what is seen in proteins with more complex amino acid sequences, allowing 
for the design of a variety of functional materials which will be discussed in depth in the 
following section.12 
1.3 Polypeptide Materials for Biomedical Applications 
 The versatile functionality of proteins is due to their ability to form ordered structures 
through hydrogen bonding within the protein backbones and non-covalent interactions involving 
the amino acid side chains.  The ability of NCA derived polypeptides to form defined structures 
makes them highly attractive for material applications.  The ability to form organized self-
assembled structures and biodegradability of polypeptide materials has led to their use in a 
variety of applications including drug delivery, gene delivery, and tissue engineering.34  
The solubility, conformation, and length of the individual polypeptide segments 
determine the type of assembly formed.  The conformations commonly employed in the design 
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of polypeptide materials are α-helices, β-sheets, and random coils.35  The flexibility of random 
coils prevent aggregation allowing for facile solvation of the peptide backbone, and facilitate 
assembly under mild conditions due their high hydrophilicity.36   α-helices, on the other hand, 
are stiff and rod-like.  Helical polypeptides are prone to dense packing, which is beneficial in the 
assembly of supramolecular materials.35  Due to their powerful interchain H-bonding, β-sheets 
are insoluble in nearly all solvents, with the exception of solvents such as TFA and concentrated 
aqueous salts such as LiBr, which also denature the chain structure.37  However, the strong 
association of β-sheets is sometimes beneficial if a strong physically crosslinked system is 
desired.38 
 
Figure 1.7 Block copolypeptide micelles with α-helical hydrophilic shell and disordered 
hydrophobic core.  Reprinted with permission from Ref. 12.  Copyright 2013 Springer Nature. 
NCA polymerization techniques have allowed for the design of amphiphilic block 
copolypeptides, which have been shown to be able to assemble into various biomedically 
relevant structures including micelles, vesicles, and hydrogels.35  Polypeptide-containing 
micelles typically consist of a flexible polyethylene glycol hydrophilic shell with a rigid 
hydrophobic polypeptide core and are utilized for the encapsulation of hydrophobic drugs.34, 39  
However, the Deming group was able to design micelles compromised solely from polypeptides 
by using a disordered racemic hydrophobic poly(Leucine) segment to facilitate spherical core 
packing in the presence of a rigid helical poly(Nε-2-[2-(2-methoxyethoxy)ethoxy]acetyl-L-lysine) 
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hydrophilic segment, KP (Figure 1.7).40   They were able to load the anticancer drug 
Campothecin into the micelles with 76% efficiency, illustrating their potential as a drug delivery 
vehicle.12 
Vesicles are of high interest in the field of drug delivery due to their ability to load both 
hydrophilic and hydrophobic cargos.41  Polymer derived vesicles have a variety of advantages 
over lipid-based vesicles due to their increased stability and tunable functionality/permeability.42  
The Deming lab has designed a variety of vesicles assembled from block copolypeptide 
amphiphiles.12  The first contained the same α-helical hydrophobic KP residues used in the block 
copolypeptides micelles described above, but also utilized a homochiral poly(L-leucine) 
hydrophobic segment, since anisotropic packing is required for bilayer assembly.  Due to the 
rigidity of the helical block copolypeptide, a denaturant (TFA) was required in the annealing 
process.43  In subsequent work, they discovered that hydrophilic segments with disordered 
conformations were most desirable for assembly of vesicles, as demonstrated with poly(L-
lysine)-block-poly(L-leucine) block copolypeptides (K60L20).  The flexibility of the hydrophilic 
segments eliminated the need for a denaturant during annealing and allowed for control of 
vesicle diameter via extrusion.36  The ability to control vesicle diameter allows for design of 
vesicles of optimal size (10 nm to 200 nm) to maximally exploit the enhanced permeability and 
retention effect via blood circulation, making this type of block copolypeptide vesicle ideal for 
cancer drug delivery.44  Polypeptides containing a cationic poly(L-arginine) hydrophilic segment 
(R60L20) assembled into vesicles that showed strong cell penetrating ability and were able to 
deliver DNA into mammalian cells for transfection.45  However, these vesicles exhibited a 
degree of cytotoxicity, which was subsequently reduced through incorporation of non-ionic, 
disordered poly(L-methionine sulfoxide) segments.46 
Hydrogels are materials that are useful in the fields of tissue engineering and cell 
delivery.  The characteristic of hydrogels that makes them desirable for these applications is 
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their highly hydrated and porous structure that mimics extracellular matrices.12  Polypeptides 
with long hydrophilic disordered segments and short helical hydrophobic segments are capable 
of forming injectable, shear thinning physical hydrogels.35  The Deming lab has designed a 
variety of hydrogels using this motif that have been used for a variety of applications.12, 38, 47 
Hydrogels with cationic poly(L-lysine) segments have been used to study spinal cord injury in 
mice and rats through localized delivery of growth factors that can facilitate axon regrowth.48, 49  
Non-ionic hydrogels containing antifouling poly(L-methionine sulfoxide) hydrophilic segments 
were shown to be an effective, non-toxic medium for the culture of neural stem/progenitor cells, 
and may prove to be a useful NSPC delivery vehicle for treatment of central nervous system 
injuries.47   
1.4 Post-polymerization Modification of Polypeptides 
 The ability to incorporate a diverse array of functionalities into polypeptides is vital for  
varying conformation, solubility, stimuli response, and cellular recognition.27, 50  Though the 20 
natural amino acids contain a variety of functional groups, the incorporation of unnatural amino 
acids is often necessary to achieve a variety of desired material properties.51   
 
Figure 1.8 Synthetic approaches to functional polypeptides with unnatural residues. 
There are two common methods for the synthesis of functional polypeptides containing 
unnatural residues: side chain modified (SCM) NCA approach and post-polymerization 
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modification (PPM) approach (Figure 1.8).  Both methods have advantages and drawbacks that 
must be considered when planning a polypeptide synthesis.  The SCM NCA approach 
guarantees full functionalization of the desired polypeptide segment.27  However, functional 
NCA’s often require complex synthesis and tedious purification, and a new monomer must be 
synthesized when a different structure or functionality is desired.52  PPM approaches may 
sometimes suffer from incomplete functionalization, but often have simple synthetic protocols 
and allow the ability to introduce a variety of functional groups and structures without the need 
to synthesize multiple monomers.27  Post-polymerization chemistry can be optimized to obtain 
complete or near complete functionality, making PPM synthetic methods highly desirable for the 
synthesis of functional polypeptide materials.53 
The most common methods of post-polymerization modification involve “click” type 
reactions.27  Defined by their high reaction rates, and lack of side products54, click reactions 
allow for high degrees of polymer functionalization under mild conditions without the formation 
of macromolecular impurities.27  Some reactions utilized for PPM of polypeptides include 
amidation55, azide-alkyne cycloaddition,21 thiol-x chemistry,56, 57 alkene oxidation chemistry58, 
and thioether alkylation chemistry.53  Some examples of reactive polypeptides that have been 
employed for PPM are shown in Figure 1.9. 
 
Figure 1.9 Selected polypeptides containing reactive handles for PPM. 
 A highly effective handle for post-polymerization modification is the thioether group.  The 
thioether group is present in the natural amino acid methionine, and can undergo reactions that 
can modify its charge, conformational preference, functionality, and reactivity (Figure 1.10).51 
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Figure 1.10 PPM of thioether functionalities in polypeptides.  Reprinted with permission from 
Ref. 51.  Copyright 2017 American Chemical Society. 
 Thioethers can undergo oxidation or alkylation reactions after polymerization.51  
Alkylation of thioether groups in polypeptides with reactive alkyl halides/triflates53 or epoxides59 
give water solubilizing, cationic sulfonium salts that can have varied functionality based on the 
alkylating agent used.  The resulting sulfonium containing polypeptides can be further modified 
a demethylation reaction to yield water soluble functional thioethers.60  Thioethers can also 
undergo oxidation to sulfoxides or sulfones depending on reaction conditions.  Poly(L-
methionine sulfoxide) is disordered in aqueous conditions and highly water soluble while Poly(L-
methionine sulfone) is α-helical with poor water solubility, likely due to strong interactions 
between sulfone groups.61  Functional thioether containing polypeptides can also be 
synthesized via post-polymerization thiol-ene chemistry and can be subsequently alkylated or 
oxidized to potentially generate a large variety of materials.57 
1.5 Stimuli-responsive Polypeptides 
 Advances in NCA polymerization techniques and innovative functionalization strategies 
have allowed for the synthesis of a variety of stimuli-responsive polypeptide materials.  Stimuli-
responsive “smart” polypeptides have potential applications in tissue engineering, drug delivery, 
and biodiagnostics.62  “Smart” polypeptides undergo chemical changes, conformational changes 
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and/or phase separation in response to a variety of stimuli including environmental cues 
(temperature, pH), biological cues (enzymes/proteins), and chemical cues such as redox.63 
 Temperature is regarded as a highly useful stimulus in the design of “smart” polypeptide 
materials.  It is highly exploitable for drug delivery due to the difference between room 
temperature and physiological temperature.64  Thermoresponsive polymers in solution 
commonly undergo phase transitions at an upper or lower critical solution temperature (UCST or 
LCST).65  The Deming lab has synthesized a variety of thermoresponsive polypeptide materials.  
Oligoethylene glycol (EG) functionalized poly(L-homocysteine) derivatives synthesized via PPM 
of L-methionine residues were shown to allow high variability of LCST depending on the type of 
EG functionality used.66  Nonionic hydrogels containing thermoresponsive EG-L-Glutamate 
residues were liquids at room temperature and formed gels under physiological conditions.  This 
material was utilized to increase survival of grafted neural stem cells 3-fold in vivo compared to 
standard media.67 
 Polypeptides that respond to changes in pH are desirable due to the lower pH of tumor 
tissue (pH 5.7-6.8)68 and intracellular compartments such as endosomes and lysosomes (pH 
4.5-6.5)69 compared to physiological pH (pH 7.4).  Polypeptide materials with polyelectrolyte 
segments containing L-lysine and/or L-glutamate residues have been utilized in the design of 
pH responsive polypeptides due to pH driven solubility changes.62  An interesting application of 
these residues was demonstrated by the Lecommandoux group.  pH responsive vesicles were 
synthesized from poly(L-glutamic Acid)15-block-poly(L-lysine) block copolypeptides. These 
vesicles showed a pH dependent assembly mechanism.  Under acidic conditions, the vesicles 
contained a neutral hydrophobic poly(L-glutamic acid) membrane layer and a cationic 
hydrophilic poly(L-lysine) corona, while basic conditions led to formation of vesicles with a 
neutral hydrophobic poly(L-lysine) membrane layer and anionic poly(L-glutamic acid) corona.70 
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 Enzyme-responsive materials are attractive for drug delivery, since many enzymes are 
overexpressed in specific diseases, and many are found only intracellularly. These qualities 
facilitate targeted drug release from enzyme-responsive nanocarriers.71  Matrix 
metalloproteinases (MMPs) are enzymes that are highly oversecreted by metastatic cancer 
cells.  Vesicles with a poly(L-lysine) corona conjugated to antifouling PEG chains via an MMP 
cleavable peptide linker (PLGLAG) were synthesized by Kim and coworkers.  Secreted MMP 
enzymes cleave between the glycine and leucine residues of the linker and release the PEG 
chains when the vesicle is in proximity to tumor cells, promoting preferential uptake.72  An 
example of utilizing an enzyme response to trigger intracellular drug release was demonstrated 
by the Deming lab.  Poly(L-methionine sulfoxide) was utilized as a hydrophilic segment for 
nonionic polypeptide vesicles.  These chains were acted on by intracellular methionine sulfoxide 
reductase (MSR) enzymes to reduce hydrophilic methionine sulfoxide residues to hydrophobic 
methionine residues, leading to vesicle disruption and cargo release.61 
 Redox chemistry is involved in many physiological processes.  The intracellular 
environment is inherently reductive due to an abundance of glutathione62, while increased 
production of reactive oxygen species (ROS) is seen in a variety of diseased cells and tissues.73  
Naturally occurring reduction and oxidation processes can be exploited for the design of stimuli 
responsive materials.71  Nanostructures with disulfide crosslinked cores have been utilized for 
reduction-triggered drug delivery74 and gene delivery75 applications.  Polypeptides containing 
residues with thioether functionality can undergo a helix to coil transition under oxidative 
conditions, which is accompanied by an increase in solubility.76   This transformation can be 
utilized to design oxidation-responsive materials such as hydrogels that degrade upon exposure 
to reactive oxygen species.73 
 The post-polymerization methodologies discussed in subsequent chapters allow for the 
design of a variety of stimuli-responsive polypeptide materials. 
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Chapter 2: Synthesis and Thiol-ene Modification of poly(L-
Homoallylglycine) 
This chapter was reproduced from P. Perlin, E. G. Gharakhanian and T. J. Deming, Chem. 
Commun., 2018, 54, 6196 with permission from The Royal Society of Chemistry 
2.1 Abstract 
Homoallylglycine N-carboxyanhydride, Hag NCA, monomers were synthesized and used 
to prepare polypeptides containing Hag segments with controllable lengths of up to 245 repeats. 
Poly(L-homoallylglycine), GHA, was found to adopt an α-helical conformation, which provided 
good solubility in organic solvents and allowed high yield functionalization of its alkene side-
chains via radical promoted addition of thiols. The conformations of these derivatives were 
shown to be switchable between α-helical and disordered states in aqueous media using 
thioether alkylation or oxidation reactions. Incorporation of GHA segments into block copolymers 
with poly(L-methionine), M, segments provided a means to orthogonally modify thioether side-
chains different ways in separate copolypeptide domains. This approach allows preparation of 
functional polypeptides containing discrete domains of oxidized and alkylated thioether 
containing residues, where chain conformation and functionality of each domain can be 
independently modified. 
2.2 Introduction 
There has been considerable recent interest in the development of methods to 
selectively introduce functional tags into peptide, protein, and polypeptide sequences.1-3 Among 
these, the thiol–ene reaction has been used extensively,4 since it can provide modifications with 
high yields and high functional group selectivity. For polypeptides, many unnatural alkene 
containing residues have been employed for subsequent thiol–ene modification (Figure 2.1).5 In 
these examples, the side-chain structures of these alkene amino acid residues have substantial 
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influence on resulting polypeptide chain lengths, conformations, solubility, and consequently the 
efficiency of thiol–ene conjugations. We sought to optimize the design of alkene containing 
residues to enable robust polypeptide and block copolypeptide synthesis, high efficiency in 
subsequent thiol–ene modifications, and control of chain conformations. 
 
Figure 2.1 (A-E) Alkene containing homopolypeptides used for thiol-ene conjugation. 
The simplest alkene containing polypeptides used for thiol–ene functionalization are 
based on allylglycine (Figure 2.1A). Both poly(L-allylglycine) and poly(DL-allylglycine) have 
been prepared and were found to adopt β-sheet conformations, which result in aggregation and 
limit the ability to prepare high molecular weight chains.6, 7 Consequently, efficient thiol–ene 
functionalization of these polymers was restricted to samples with short chain lengths (i.e. 
typically <20 residues), and often required incorporation of comonomers or segments (i.e. PEG) 
to promote solubility.8, 9 Related polypeptides have been prepared based on alkene 
functionalized serine10 and cysteine11 residues (Figure 2.1B and C) that also adopt β-sheet 
conformations leading to poorly controlled chain aggregation, which would be problematic for 
downstream use as segments in block copolypeptide assemblies. 
Additional studies have utilized functionalized glutamate esters as components for 
preparation of alkene containing polypeptides (Figure 2.1D and E).12-14 These polypeptides have 
the advantage of adopting α-helical conformations, which possess good solubility and allow 
formation of high molecular weight chains. Homopolypeptides up to 100 residues long were 
prepared and could be efficiently modified with different thiols yielding α-helical derivatives. 
While this strategy is useful for preparation of homopolypeptides, the labile side-chain ester 
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linkages would be problematic in preparation of multifunctional copolypeptides.15 Also, this 
strategy only allows for preparation of polypeptides with α-helical conformations, which cannot 
be switched due to their long, hydrophobic side-chains.12-14 Polypeptides with conformations that 
can be switched reversibly under mild conditions are desirable for use in development of self-
assembled materials such as nanocarriers and hydrogels that can actively respond to biological 
and chemical cues. 
 
Figure 2.2 Comparison of allyl, homoallyl, and pentenyl glycine homopolypeptides. 
To take full advantage of the thioether functionality introduced by thiol–ene conjugation, 
we sought to develop polypeptides containing alkene side-chains of minimal length so that 
modifications of product thioether groups would induce switchable chain conformations.16 
Further, to enable preparation of soluble, high molecular weight chains, α-helical conformations 
were desired for the initial alkene bearing polypeptides. While poly(allylglycine)s are known to 
form β-sheets, it has also been reported that poly(L-pentenylglycine) adopts an α-helical 
conformation (Figure 2.2).6, 7 While poly(L-pentenylglycine) has not been used for thiol–ene 
conjugation, its hydrophobic side-chains might be too long to allow conformational switching, 
similar to the glutamate derivatives described above. Since single carbon homologation of side-
chain functional groups in β-sheet forming polypeptides can result in polypeptides that adopt α-
helical conformations, such as homologation of cysteine to homocysteine,17 we hypothesized 
that the intermediate side-chain length of Hag would be sufficiently long to stabilize α-helical 
conformations in GHA and yet be short enough to allow introduced thioether groups to influence 
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chain conformations (Figure 2.2). Notably, Hag has also been utilized as an artificial residue for 
efficient thiol–ene modification in proteins.18, 19  
Consequently, we sought to develop procedures for preparation of new NCA monomers 
of L-Hag and rac-Hag, and synthesize their corresponding new homopolypeptides (Figure 2.3). 
To enhance the ability to prepare multifunctional polypeptides with stimulus responsive 
conformations, we also sought to prepare block copolypeptides of Hag with L-methionine, Met. 
Specifically, we aimed to utilize Hag residues as “masked” precursors of thioether groups, which 
could be functionalized orthogonally to the thioether groups in Met residues. The goal of this 
approach being the preparation of block copolypeptides where discrete domains can be 
functionalized and conformationally switched independent of one another. 
 
Figure 2.3 Synthesis of homoallylglycine NCAs and polypeptides. 
2.3 Results and Discussion 
 
Figure 2.4 Synthetic schemes for homoallylglycine amino acids. 
 For NCA monomer preparation, the Hag and rac-Hag amino acid precursors were 
prepared following literature methods (Figure 2.4).18-22 rac-Hag was obtained by alkylation of 
diphenylimino glycine tert-butyl ester, which gave the free amino acid directly upon hydrolysis of 
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the protecting groups. Hag was prepared by alkylation of diethyl acetamidomalonate, followed 
by ester deprotection and decarboxylation to give N-acetyl-rac-Hag. This racemic mixture was 
readily resolved by enantioselective hydrolysis catalyzed by porcine acylase to give multigram 
quantities of Hag (Figure 2.5), which possessed an enantiomeric excess of >99% suitable for 
preparation of NCAs and polypeptides with high optical purity. 
 
Figure 2.5 Chiral HPLC Chromatograms of N-(carbobenzyloxy)-DL-homoallylglycine (A) and N-
(carbobenzyloxy)-L-homoallylglycine (B).  Amino Acids were N-protected to give solubility in 
mobile phase. 
A
B
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 Analysis of both Hag and rac-Hag matched literature data.18-22 Hag and rac-Hag were each 
subsequently treated with phosgene under standard conditions to obtain the corresponding 
NCAs that were obtained as high purity colorless solids after column chromatography and 
recrystallization (Figure 2.6).23  
 
Figure 2.6 FTIR and GPC data for Hag NCA and rac-Hag NCA.  TOP: FTIR Spectrum of Hag 
NCA (A) and rac-Hag NCA (B) (50 mg/mL in THF).  Note NCA bands at 1856 and 1790cm-1, 
and alkene stretch at 1642cm-1.  BOTTOM: SEC chromatogram of Hag NCA (C) and rac-Hag 
NCA (D) in 0.5% (w/w) KTFA in HFIP. RIU = arbitrary refractive index units. 
Homopolymerizations of Hag and rac-Hag NCAs at different monomer to initiator (M : I) 
ratios were conducted using Co(PMe3)4 initiator in THF.24 While Hag NCA polymerizations 
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rapidly went to completion and remained homogeneous up to M : I = 80 (Figure 2.7A), the rac-
Hag NCA polymerizations did not go to completion above M : I = 20 (Figure 2.8). By FTIR we 
observed the poly(DL-homoallylglycine), (rac-GHA), forms β-sheet aggregates during 
polymerization that likely inhibit chain growth (Figure 2.9).6, 7 On the contrary, GHA 
homopolymers were found to be highly α-helical in organic solvents (Figure 2.7B), which 
promoted good solubility and enabled the synthesis of polymers up to 245 residues long. 
 
Figure 2.7 Synthesis and properties of poly(L-homoallylglycine), GHA. (A) Number average 
molecular weight (Mn) of GHA plotted as a function of monomer to initiator ratio (M : I) at 
complete monomer conversion using Co(PMe3)4 in THF (r2 = 0.9874). Mn values were 
determined by 1H NMR analysis of PEG end-capped polymers. (B) Circular dichroism spectrum 
of GHA in 15 : 1 : 2 cyclohexane : MeCN : IPA (0.5 mg/mL) at 20 °C. Molar ellipticity reported in 
deg cm2 dmol−1. 
 Analysis of chain lengths at different M : I showed linear chain growth during Hag NCA 
polymerization, an indicator of controlled polymerization (Figure 2.7A). GPC analysis of GHA 
samples, derivatized using thiol–ene reactions to improve solubility (Figure 2.10), gave 
unimodal peaks with dispersities of ca. 1.1–1.2, confirming the formation of uniform polymers.  
190 200 210 220 230 240
-4
-2
0
2
4
[
] 
X
 1
0
-3
Wavelength (nm)
20 30 40 50 60 70 80
5
10
15
20
25
30
M
n
 x
 1
0
-3
M:I
A B
26 
 
M:I Monomer 
Conversion 
DP Mw/Mn Yield (%) 
20 Complete 44 1.13 96 
40 Incomplete N/A N/A 87 
60 Incomplete N/A N/A 65 
80 Incomplete N/A N/A 63 
Figure 2.8 Synthesis of (rac-GHA) at different monomer to initiator ratios (M:I) using Co(PMe3)4 
initiator in THF at 20 °C.  DP = number average degree of polymerization. Yield is the total 
isolated yield of purified polypeptide. N/A = Not determined due to incomplete polymerization 
reaction. 
 
Figure 2.9 Solid state FTIR of rac-GHA43.  The Amide I and Amide II bands at 1626 and 1529 
cm-1, respectively, are characteristic of a β-Sheet conformation. 
To further test the ability of Hag NCA to undergo controlled polymerization, diblock 
copolypeptides with Met NCA were prepared (Figure 2.11). Block copolypeptides of defined 
sequence and composition were obtained in excellent yields, and GPC analysis of derivatized 
copolymers (vide infra) showed uniform chain length distributions with low dispersity (Figure 
2.10). 
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Figure 2.10 GPC chromatograms of derivatized homo and diblock polypeptides Glc(OAc)4-
GHA27 (blue) and Glc(OAc)4-GHA27MM80 (red) in HFIP containing 0.5% (w/w) KTFA. S = solvent. 
RIU = arbitrary refractive index units. 
 
Figure 2.11 Synthesis of diblock copolypeptides using Co(PMe3)4 in THF at 20 oC.  First and 
second monomers were added stepwise to the initiator.   Molecular weight and Dispersity 
determined by 1H NMR and GPC of derivatized polypeptides. 
 After successful polymerization of Hag NCA, the reactivity of GHA with a variety of thiols 
was evaluated. Toward the goal of obtaining water soluble derivatives, oligoethylene glycol and 
monosaccharide thiols were chosen for these studies (Figure 2.12). Under optimized conditions, 
near quantitative thiol–ene functionalization of Hag residues was obtained for all thiols (see 
experimental).18, 19 For comparison, thiol–ene functionalization of (rac-GHA) was also attempted 
using similar conditions (see experimental). While >90% thiol conjugation efficiency could be 
obtained on short (rac-GHA) chains, these derivatives exhibited poor water solubility due to the 
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formation of β-sheet structures (Figure 2.13). Contrary to this result, all thiol–ene derivatives of 
GHA were found to possess good water solubility, except for mEG3-GHA, which was soluble in 
organic solvents. 
 
Figure 2.12 Thiol–ene modification of GHA (4 mg/mL) in THF with UV irradiation followed by 
overnight stirring at ambient temperature. Funct = percentage of side-chain modification. Yield = 
total isolated yield of purified polypeptide. Quant. = quantitative. 
 
Figure 2.13 Solid state FT-IR of mEG4-(rac-GHA)43.  The Amide I and Amide II bands at 1625 
and 1521 cm-1, respectively, are characteristic of a β-Sheet conformation. 
 Aqueous solutions of GHA derivatives analyzed by circular dichroism (CD) spectroscopy 
were found to primarily adopt α-helical conformations, similar to the parent GHA (Figure 2.14A). 
α-Helical content was found to be greatest (ca. 100% α-helix) for the EG4-GHA sample, which 
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contained side-chains with greatest hydrophilicity. The methoxy terminated oligoethylene glycol 
and glycosylated samples (mEG3-GHA, mEG4-GHA, and Glc-GHA) possessed diminished minima 
at 208 and 222 nm, yet retained partial helical content (49 to 71% α-helix). The addition of 
hydrophilic thiols to GHA was found to be an efficient means to obtain water soluble, α-helical 
polypeptides with high degrees of functional modification. 
 
Figure 2.14 Circular dichroism spectra of functionally modified GHA63 samples. (A) Thiol–ene 
adducts mEG3-GHA (blue), mEG4-GHA (red), EG4-GHA (black), Glc-GHA (green). All samples in DI 
water except mEG3-GHA in THF. (B) Parent mEG4-GHA (blue, 71% α-helix) and its sulfonium 
(black, 0% α-helix) and sulfoxide (red, 22% α-helix) derivatives in DI water. All samples (0.5 
mg/mL) analyzed at 20 °C. Molar ellipticity reported in deg cm2 dmol−1.  Percent α-helical 
content of polypeptides was estimated using the formula % α-helix = 100 × (−[θ]222 + 
3000)/39000), where [θ]222 is the measured molar ellipticity at 222 nm.25   
Since functionalized GHA contain thioether linkages, there is potential for additional 
secondary modification of the polypeptide side-chains via selective alkylation or oxidation 
reactions.16 To examine the feasibility of such modifications and test their effects on polymer 
properties, mEG4-GHA was reacted separately with either iodomethane or tert-
butylhydroperoxide (TBHP) to obtain the methylated derivative, mEG4-GHAM, or oxidized 
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derivative, mEG4-GHAO, respectively (Figure 2.15). These reactions gave high yields of the fully 
modified polypeptides, which retained the water solubility of the precursor mEG4-GHA. CD 
analysis of mEG4-GHAM and mEG4-GHAO in water revealed that both modifications destabilized 
the α-helical conformation of the parent mEG4-GHA (Figure 2.14B), similar to results obtained for 
alkylation and oxidation of thioether containing M chains even though the thioether groups in 
mEG4-GHAM are two bonds further removed from the peptide backbone compared to Met 
residues.16 The degree of conformational disruption was greater for mEG4-GHAM, likely due to 
the introduction of charged groups as compared to the non-ionic sulfoxides in mEG4-GHAO. This 
ability to switch between α-helical and disordered conformations in mEG4-GHA polypeptides is a 
desirable feature that has not been demonstrated in thiol–ene derivatives of other alkene 
containing polypeptides. 
 
Figure 2.15 Conformational changes induced by thioether alkylation or oxidation of mEG4-
GHA63. 
 To illustrate how GHA segments can be used in conjunction with other polypeptide 
segments to obtain chains with discrete modified thioether domains, we sought to prepare 
diblock copolypeptides containing both sulfoxide and sulfonium functionality in separate 
segments (Figure 2.16). Independent control over placement of bio-inert segments, i.e. 
sulfoxide,26, 27 and segments that may promote cell uptake, i.e. sulfonium,28 is needed for 
continued development of multifunctional biomaterials. While both sulfoxide and sulfonium 
groups can be introduced into M homopolymers, there is no means to control placement of 
these groups as they will be statistically distributed along the chains. In our experience, due to 
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limited solubility of M in suitable reaction media, precise control over partial oxidation or partial 
alkylation of M chains is challenging. Hence, methodology for facile installation of sulfoxide and 
sulfonium functionality in discrete segments within copolypeptide sequences would be valuable. 
 
Figure 2.16 Synthesis of diblock copolypeptide MO42mEG4-GHAM19 that contains discrete 
sulfoxide and sulfonium domains. Percent yields are total isolated yields of purified 
copolypeptides. 
 To demonstrate the feasibility of such modifications, a block copolymer of Met and Hag, 
M42GHA19 prepared as described above, was subjected to a sequence of selective reactions 
(Figure 2.16). Hydrophobic, α-helical M42GHA19 was first oxidized at Met residues to give the 
amphiphilic copolymer MO42GHA19 containing disordered hydrophilic poly(L-methionine 
sulfoxide), MO, segments.26, 27 The thiol mEG4SH was then selectively added to the Hag 
residues via radical coupling in acidic media, which is beneficial for thiol–ene conjugation and 
also prohibits undesirable reduction of sulfoxides by thiols. The resulting copolymer, 
MO42mEG4-GHA19, now became fully hydrophilic, but retained α-helical conformations in the 
mEG4-GHA domains. The thioether groups in this copolymer were then selectively alkylated 
using iodomethane, taking advantage of the resistance of MO residues toward alkylation under 
these conditions.29 The resulting sulfoxide-sulfonium diblock copolypeptide, MO42mEG4-GHAM19, 
was water soluble and both segments were now conformationally disordered in water. In 
addition to successful selective functional modification of each copolypeptide domain, the 
respective thioether modifications also allowed independent conformational switching of each 
segment (Figure 2.17). 
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Figure 2.17 Circular dichroism spectra of M42GHA19 and its derivative block copolypeptides at 
0.1 mg/mL, 20 oC.  M42GHA19 (blue, in THF), MO42mEG4-GHA19 (red, in DI water, 25% α-helix), 
MO42mEG4-GHAM19 (black, in DI water, 12% α-helix). The derivative MO42GHA19 possessed poor 
solubility in both organic and aqueous solvents and was not analyzed. 
2.4 Conclusion 
The efficient polymerization of Hag NCA, good solubility of GHA allowing preparation of 
high molecular weight homo- and copolymers, facile modification of Hag residues with thiols, 
and ability to further modify the thioether products provide a number of attractive features 
supporting utilization of Hag residues in peptidic materials. Beyond what has been achieved in 
previous alkene containing polypeptides, the example process in Figure 2.16 shows how 
incorporation of Hag residues into polypeptides can be used to differentially modify discrete 
segments in an orthogonal manner and also modulate polypeptide chain conformations. 
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2.5 Experimental 
2.5.1 Materials and Methods 
 Unless specified, all post-polymerization modification chemistry was performed in glass 
vials under ambient atmosphere.  Thiol-ene reactions were performed in 1 dram screw top glass 
vials capped with septa to allow sparging.  An Exo Terra Repti-Glo 5.0 compact fluorescent 
tropical terrarium lamp was used as the ultraviolet light source.  Small molecule chemistry was 
performed in heat-dried glassware under a nitrogen atmosphere, unless otherwise specified. 
THF and hexanes were degassed with dinitrogen and passed through an alumina column 
before use. All other reagents and solvents were used as received. Unless otherwise specified, 
all reactions were performed at ambient temperature (ca. 20 °C).  In-house deionized water was 
used for all aqueous chemistry and dialysis unless otherwise specified.  Circular dichroism (CD) 
spectroscopy was performed on samples prepared using deionized water filtered through a 
Millipore Milli-Q Biocel A10 filter system unless otherwise specified. CD spectra were collected 
using 0.1 or 0.5 mg/mL solutions of polypeptide on an Olis DSM 10 spectrophotometer using a 
0.1 cm path length quartz cuvette.  Percent α-helical content of polypeptides was estimated 
using the formula % α-helix = 100 × (−[θ]222 + 3000)/39000), where [θ]222 is the measured molar 
ellipticity at 222 nm.  Thin-layer chromatography was performed with EMD gel 60 F254 plates 
(0.25 mm thickness) and spots were visualized using a UV lamp or KMnO4 stain.  Silicycle 
Siliaflash G60 silica (60-200 µm) was used for all column chromatography.  Silica used for 
chromatographic purification of NCA monomers was dried under vacuum at 250 °C for 48 hours 
and then stored in a dinitrogen filled glovebox.  Compositions of mobile phases used for 
chromatography and compositions of solvent systems used for circular dichroism are given in 
volume percents.  Dialysis was performed with regenerated cellulose tubing obtained from 
Spectrum labs.  NMR spectra were recorded on a Bruker AV400 instrument with chemical shifts 
reported relative to the deuterated solvent used.  Infrared spectra of solution samples were 
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collected using a Perkin Elmer 1605 FT-IR Spectrophotometer.  Solid state FTIR spectra were 
collected using a Perkin Elmer Spectrum One FT-IR Spectrophotometer with a Perkin Elmer 
Universal ATR Sampling Accessory.  DART-MS spectra were collected on a Thermo Exactive 
Plus MSD (Thermo Scientific) equipped with an ID-CUBE ion source at the low desorption 
setting and a Vapur Interface (IonSense).  Both the source and MSD were controlled by 
Excalibur v. 3.0.  Analytes were dissolved 1 mg/mL in 1:3 THF:MeCN and spotted onto 
OpenSpot sampling cards (IonSense).  Ionization was accomplished using He plasma with no 
additional ionization agents.  Mass calibration was carried out using Pierce LTQ Velos ESI (+) 
and (-) Ion calibration solutions (Thermo Fisher Scientific).  Tandem gel permeation 
chromatography/light scattering (GPC/LS) was performed at 25 oC using an SSI Accuflow 
Series III pump equipped with Wyatt DAWN EOS light scattering and Optilab REX refractive 
index detectors. Separations were achieved using 100 Å and 1000 Å PSS-PFG 7 μm columns 
at 30 ºC with 0.5% (w/w) KTFA in 1,1,1,3,3,3-hexafluoroisopropanol (HFIP) as eluent and 
sample concentrations of 10 mg/ml.  Enantiomeric excess of L-Hag was measured against a 
racemic standard using an Agilent 1260 Infinity HPLC.  Separations were achieved using a 
Chiralpak AD-H 5 μm column with 10% isopropanol in hexanes as eluent and sample 
concentrations of 1 mg/ml.  Melting points were measured using a DigiMelt MPA160 SRS 
melting point apparatus with a ramp rate of 5 oC/minute. 
2.5.2 Synthesis of Amino Acids and NCA Monomers 
 
N-(Diphenylmethylene)-DL-homoallylglycine tert-butyl ester. This compound was 
synthesized by following a previously reported method.1 A 10% THF solution of potassium tert-
butoxide (1.9 g, 17 mmol) was added dropwise to a 10% THF solution of N-
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(diphenylmethylene)-glycine tert-butyl ester (2.5 g, 8.5 mmol) at -70 °C (EtOAc/liquid nitrogen 
bath).  After 15 minutes, 2.0 mL (20 mmol) 3-butenyl bromide was added via syringe. The 
reaction was let warm to ambient temperature then transferred to a 30 °C water bath and let stir 
overnight. The reaction was then let cool to ambient temperature and quenched with 30 mL of 
saturated ammonium chloride solution. The resulting layers were partitioned in a separatory 
funnel, and the aqueous layer was then extracted with 4 x 25 mL DCM. Combined organic 
extracts were washed with brine, dried with anhydrous sodium sulfate, and volatiles were 
removed under reduced pressure.  The resulting oil was purified by silica gel chromatography 
with 8 % EtOAc in hexanes as mobile phase.  Solvent was removed under reduced pressure to 
yield the product as a pale yellow oil (2.8 g, 93% yield). 1H NMR (400 MHz, CDCl3, 25 °C): δ 
7.68-7.56 (br m, 2H), 7.52-7.29 (br m, 6H), 7.21-7.12 (br m, 2H), 5.80-5.66 (dq, J = 27.2, 6.1 Hz, 
1H), 5.00-4.86 (br m, 2H), 3.93, (t, J = 6.2 Hz, 1H) 2.15-1.93 (br m, 4H), 1.44 (s, 9H). 
 
DL-Homoallylglycine hydrochloride, rac-Hag. This compound was synthesized by following a 
previously reported method.20 N-(Diphenylmethylene)-DL-homoallylglycine tert-butyl ester (1.72 
g) was suspended in 27.5 mL of 2 M aqueous HCl, and stirred rapidly at ambient temperature 
for 3 hours.  The suspension became a clear solution in 60 minutes and a yellow oil began to 
separate.  Organic byproducts were removed by washing the reaction mixture with 3 x 20 mL 
DCM.  The aqueous layer was then concentrated under reduced pressure and further 
concentrated under high vacuum to give the product as a white solid (654 mg, 85% yield). 1H 
NMR (400 MHz, D2O, 25 °C): δ 5.82-5.71 (br m, 1H), 5.08-5.01 (dq, J = 17.2, 1.6 Hz, 1H) 5.01-
4.96 (dd, J = 11.8, 8.8 Hz, 1H), 3.87 (t, J = 12.5 Hz, 1H), 2.14-2.06 (q, J = 7.0 Hz, 2H), 2.01-
1.81 (br m, 2H). Spectral data were consistent with previously published results.1 
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Diethyl 2-homoallyl-2-acetamidomalonate.  This compound was synthesized by following a 
previously reported method.21  A solution of diethyl 2-acetamidomalonate (45 g, 210 mmol, 1.0 
eq) in DMF (300 mL) was prepared in a round bottom flask and capped with a septum.  
Separately, a suspension of 60 % NaH (9.1 g, 230 mmol, 1.1 eq) in DMF (100 mL) was 
prepared in a Schlenk flask and stirred in an ambient temperature water bath under N2 
atmosphere.  The malonate solution was slowly cannula transferred into the NaH suspension 
(caution: exothermic).  The resulting mixture was stirred 10 min.  3-Butenyl bromide (23 mL, 230 
mmol, 1.1 eq) was then added in one portion via syringe.  The mixture was stirred for 16 h on a 
60 °C oil bath, and then quenched with AcOH (2 mL) and concentrated by rotary evaporation, 
then using high vacuum.  The residue was dissolved in Et2O (250 mL) and washed with H2O (2 
x 200 mL), and then the organic phase was dried over MgSO4 and concentrated by rotary 
evaporation.  This crude material was purified by column chromatography (25-35% 
EtOAc/hexanes) to provide diethyl 2-homoallyl-2-acetamidomalonate as a pale yellow solid (43 
g, 76% yield).  RF = 0.32; 25% EtOAc/hexanes. 1H NMR (400 MHz, CDCl3, 25 °C): δ 6.79 (s, 1 
H), 5.75 (ddq, J = 17.1, 10.3, 6.5 Hz, 1 H), 5.03 (dq, J = 17.1, 1.7 Hz, 1 H), 4.97 (dq, J = 10.2, 
1.5 Hz, 1 H), 4.25 (q, J = 7.1 Hz, 4 H), 2.45 (m, 2 H), 2.04 (s, 3 H), 1.92 (m, 2 H), 1.25 (t, J = 
7.0, 6 H). 
 
N-acetyl-DL-homoallylglycine.  This compound was synthesized by following a previously 
reported method.21  Diethyl 2-homoallyl-2-acetamidomalonate (13 g, 49 mmol) was suspended 
in aqueous 1 N KOH (2.6 eq).  The mixture was refluxed with vigorous stirring.  The initially 
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biphasic mixture became homogenous after ca. 30 min.  Heating was maintained for 3 h in total.  
The mixture was adjusted to pH 3.5 (temperature compensated) with conc. HCl.  The mixture 
was then refluxed for an additional 1 h.  The pH was then adjusted again back to pH 3.5 using 
conc. HCl (Note: the pH rises as the decarboxylation progresses).  The mixture was again 
refluxed for an additional 2 h then allowed to cool to ambient temperature.  The solution was 
then concentrated to about 2/3 its original volume by rotary evaporation.  The resultant amber 
mixture was treated with activated charcoal (12 mL of powder).  After stirring for 10 min, the 
suspension was filtered.  The colorless filtrate was adjusted to pH 2.0 with conc. HCl.  This 
mixture was then extracted with 4 x 80 mL of EtOAc. The organic extracts were dried over 
Na2SO4 and concentrated by rotary evaporation to provide N-acetyl-DL-homoallylglycine (7.7 g, 
96% yield) as a colorless solid. 1H NMR (400 MHz, D2O, 25 °C): δ 5.89 (ddq, J = 17.2, 10.3, 6.8 
Hz, 1 H), 5.12 (dq, J = 17.2, 1.7 Hz, 1 H), 5.06 (m, 1 H), 4.35 (dd, J = 9.5, 4.7 Hz, 1 H), 2.21 (m, 
2 H), 2.06 (s, 3 H), 2.01 (m, 1 H), 1.86 (m, 1 H).  
 
 
L-Homoallylglycine.  This compound was synthesized by following a previously reported 
method.21 A 300 mM aqueous solution of N-acetyl-DL-homoallylglycine (46 g, 290 mmol) 
containing 5 mM KH2PO4 was prepared in a Schlenk flask. The solution was adjusted to pH 7.5-
8.0 with aqueous 4 N KOH.  The mixture was placed in a 40 °C oil bath and degassed by stirring 
under N2 for 15 min.  Porcine amino acylase (4.2 U per mmol of N-acetyl-DL-homoallylglycine) 
was added and the reaction mixture was gently stirred.  At selected time points 50 µL aliquots 
were removed and analyzed using a ninhydrin colorometric assay.21  The pH of the solution was 
periodically measured and if necessary readjusted to pH 7.5-8.0 by addition of 4 N KOH.  When 
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the ninhydrin assay showed no further increase in amino acid concentration, the resolution 
reaction was terminated by briefly heating the mixture to 60 oC followed by stirring with activated 
charcoal (72.5 mL of powder).  The mixture was vacuum filtered to yield a colorless filtrate, 
which was adjusted to pH 1.5 with conc. HCl, and then washed with EtOAc (3 x 490 mL).  The 
aqueous phase was applied onto a Dowex® 50WX8 column (490 mL) and desalted by flushing 
the column with H2O until the eluent reached neutral pH followed by desorption of the amino 
acid by eluting with aqueous 1.0 N NH3.  L-Homoallylglycine was recovered as a colorless solid 
after rotary evaporation followed by lyophilization (15.3 g, 92% yield based on amount of N-
acetyl-L-homoallylglycine).  1H NMR (400 MHz, 0.5 % TFA-d/D2O, 25 °C): δ 5.80 (m, 1 H), 5.09 
(m, 1 H), 5.02 (m, 1 H), 4.02 (m, 1 H), 2.15 (m, 2 H), 2.0 (m, 2 H). [α]D
24 = +27.4 (c 1.00, 1 N 
HCl). Spectral data were consistent with previously published results.21 
 
 
N-(Carbobenzyloxy)-DL-homoallylglycine.  DL-Homoallylglycine hydrochloride (104 mg, 0.64 
mmol) was dissolved in DI water (9.0 mL).  Sodium bicarbonate (586 mg, 7.0 mmol) was added 
to the resulting solution and the reaction mixture was let stir at room temperature for 10 minutes.  
The reaction was then cooled to 0 °C and benzyl chloroformate (144 mg, 0.84 mmol) was added 
dropwise.  The reaction was let warm to room temperature overnight with vigorous stirring.  The 
reaction mixture was transferred to a separatory funnel and washed with 4 x 6 mL Et2O.  The 
aqueous layer was then brought to pH 2 with 3M HCl and extracted with 4 x 5 mL EtOAc.  The 
EtOAc extracts were dried with Na2SO4, decanted, concentrated under reduced pressure and 
further concentrated under vacuum to give a white solid (79.4 mg, 48% yield). 1H NMR (400 
MHz, CDCl3, 25 °C): δ 7.42-7.28 (br m, 5H), 6.02-5.68 (br m, 1H), 5.32-4.92 (br m, 5H), 4.51-
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4.22 (br m, 1H), 2.22-2.10 (q, J = 7.1 Hz, 2H), 2.10-1.72 (br m, 2H). 13C  NMR (100 MHz, CDCl3, 
25 °C): δ 177.3, 156.1, 136.6, 136.1, 128.6, 128.3, 128.2, 116.1, 67.2, 53.3, 31.5, 29.4. MP = 
104.0-105.2 °C. 
  
N-(Carbobenzyloxy)-L-homoallylglycine.  L-Homoallylglycine (58 mg, 0.46 mmol) was 
dissolved in 1M sodium bicarbonate (5 mL) and let stir for 10 minutes. The reaction was then 
cooled to 0 °C and benzyl chloroformate (108 mg, 0.63 mmol) was added dropwise.  The 
reaction was let warm to room temperature overnight with vigorous stirring.  The reaction 
mixture was transferred to a separatory funnel and washed with 4 x 3 mL Et2O.  The aqueous 
layer was then brought to pH 2 with 3M HCl and extracted with 4 x 2 mL EtOAc.  The EtOAc 
extracts were dried with Na2SO4, decanted, concentrated under reduced pressure and further 
concentrated under vacuum to give a white solid (90 mg, 75% yield).  1H NMR (400 MHz, 
CDCl3, 25 °C): δ 7.40-7.29 (br m, 5H), 6.06-5.65 (br m, 1H), 5.37-4.88 (br m, 5H), 4.52-4.18 (br 
m, 1H), 2.25-2.09 (q, J = 7.1 Hz, 2H), 2.09-1.71 (br m, 2H). 13C NMR (100 MHz, CDCl3, 25 °C): 
δ 177.3, 156.1, 136.6, 136.1, 128.6, 128.3, 128.2, 116.1, 67.2, 53.3, 31.6, 29.4.   MP = 69.3-
71.8 °C. 
Amino acid N-carboxyanhydride (NCA) monomer syntheses.   NCA monomers were 
prepared using a previously established method.23  Caution! Phosgene is extremely 
hazardous and all manipulations must be performed in a well-ventilated chemical fume 
hood with proper personal protection and necessary precautions taken to avoid 
exposure.  After evaporation of crude reaction mixtures to dryness using a Schlenk manifold, 
crude products, in sealed Schlenk flasks under vacuum, were brought into a dinitrogen filled 
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glovebox for purification.  The method of purification varied for each monomer, as detailed 
below. 
 
L-Methionine N-carboxyanhydride, Met NCA. Purified via column chromatography using 33% 
THF in hexanes.  Spectral data were consistent with previously published results.23 
 
 
DL-Homoallylglycine N-carboxyanhydride, rac-Hag NCA.  Purified via column 
chromatography using 33 % THF in hexanes.  DL-Homoallylglycine hydrochloride (590 mg) was 
used to prepare rac-Hag NCA, which was obtained as a colorless solid (408 mg, 73% yield). 1H 
NMR (400 MHz, CDCl3, 25 °C): δ 6.40 (s, 1H), 5.84-5.71 (br m, 1H), 5.18-5.08 (m, 2H), 4.37-
4.31 (m, 1H), 2.33-2.20 (q, J = 6.9 Hz, 2H), 2.13-2.03 (m, 1H), 1.93 (pent, J = 7.1 Hz, 1H). 13C 
NMR (100 MHz, CDCl3, 25 °C): δ 169.7, 153.0, 135.6, 117.3, 57.1, 30.8, 29.1.  DART-MS m/z = 
154.05 [M – H]- (calcd for C7H8O3N: 154.05). MP = 63.8-65.4 °C. 
 
L-Homoallylglycine N-carboxyanhydride, Hag NCA.  Purified via column chromatography 
using 33% THF in hexanes, followed by 2x recrystallization from THF/hexanes at -35 °C.  L-
Homoallylglycine (460 mg) was used to prepare Hag NCA, which was obtained as a white solid 
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(370 mg, 66% yield).  1H NMR (400 MHz, CDCl3, 25 °C): δ 6.51 (s, 1H), 5.85-5.70 (br m, 1H), 
5.18-5.07 (m, 2H), 4.37-4.31 (br m, 1H), 2.33-2.20 (br m, 2H), 2.13-2.03 (m, 1H), 1.93 (pent, J = 
7.2 Hz, 1H).  13C NMR (100 MHz, CDCl3, 25 °C): δ 169.7, 153.0, 135.5, 117.4, 57.1, 30.8, 29.2   
DART-MS m/z = 154.05 [M – H]- (calcd for C7H8O3N: 154.05). MP = 41.6-43.1 °C.  
2.5.3 Homopolymerizations of Hag and rac-Hag NCAs 
General Procedure for Polymerization of Hag NCA.  All polymerization reactions were 
performed in a dinitrogen filled glove box using anhydrous solvents. To a solution of Hag NCA in 
THF (164 mg, 1.05 mmol, 25 mg/mL) was added a solution of Co(PMe3)4 in THF (970 μL, 52.5 
μmol).  Once mixed, the reaction was let stand at ambient temperature for 1-2 h, and completion 
of polymerization was confirmed by FTIR.  Polymerization at all different monomer to initiator 
feed ratios used were found to be complete within 2 h.  The completed reaction was removed 
from the glove box and 1-2 drops of 3 M HCl were added.  The polymer was then precipitated 
with DI water, centrifuged at 3000 rpm, and the supernatant was discarded.  The pellet was 
washed 3 times with DI water and then lyophilized to yield poly(L-homoallylglycine), GHA, as a 
white solid (105 mg, 95% yield).  1H NMR (400 MHz, TFA-d, 25 °C): δ 5.87-5.70 (dq, J = 17.7, 
14.2 Hz, 1H), 5.17-5.01 (br m, 2H), 4.74-4.70 (dd, J = 8.4, 7.0 Hz, 1H), 2.28-2.08 (br m, 2H), 
2.07-1.87 (br m, 2H). 
General procedure for polymerization of rac-Hag NCA. All polymerization reactions were 
performed in a dinitrogen filled glove box using anhydrous solvents. To a solution of rac-Hag 
NCA in THF (173 mg, 1.11 mmol, 25 mg/mL) was added a solution of Co(PMe3)4 in THF (1.00 
mL, 55.0 μmol).  Once mixed, the reaction was let stand at ambient temperature for 2 h, and 
completion of polymerization was confirmed by FTIR. Only polymerizations with M:I ratios up to 
20:1 were found to go to completion within 2 hours, polymerizations at higher M:I ratios did not 
go to completion even after many hours.  After 2 hours, the reaction was removed from the 
glove box and 1-2 drops of 3 M HCl were added. The polymer was then precipitated with DI 
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water, centrifuged at 3000 rpm, and the supernatant was discarded. The pellet was washed 3 
times with DI water and then lyophilized to yield poly(DL-homoallylglycine), (rac-GHA), as a 
white solid (100 mg, 85% yield). 1H NMR (400 MHz, TFA-d, 25 °C): δ 5.92-5.72 (br m, 1H), 5.17-
5.01 (br m, 2H), 4.74 (br s, 1H), 2.34-2.13 (br m, 2H), 2.13-1.89 (br m, 2H). 
General procedure for endcapping of polypeptides with PEG chains.  The general 
procedure for polymerization of Hag NCA was followed.  Once the reaction was determined to 
be complete by FTIR, a solution of α-methoxy-ω-isocyanoethyl-poly(ethylene glycol), PEG-NCO 
(MW = 1000 Da, 4 eq per Co(PMe3)4) in THF was added to the polymerization mixture inside a 
dinitrogen filled glovebox.  The reaction was let stand overnight, and then removed from the 
glovebox. 1-2 drops of 3M HCl were then added and the reaction was precipitated with water, 
centrifuged at 3000 rpm and the supernatant was discarded.  The pellet was washed 3 times 
with DI water to remove unconjugated PEG-NCO, and the resulting pellet was then lyophilized 
to yield PEG-endcapped polypeptide as a white solid.  To determine the molecular weight of the 
polypeptides (Mn), 1H NMR spectra were obtained in deuterated trifluoroacetic acid (TFA-d) or 
deuterated chloroform (CDCl3) containing 1-2 drops of TFA-d. Similar to procedures described 
in literature,30 the integral of the alkene proton resonance of GHA at 5.17-5.01 ppm was 
compared to the integral of the polyethylene glycol resonance at δ 4.01 (TFA-d) or δ 3.64 
(CDCl3/ TFA-d) to obtain GHA lengths. 
2.5.4 Thiol-ene modification of GHA and (rac-GHA) homopolypeptides 
 
p-Toluenesulfonyl triethylene glycol methyl ether.  This compound was synthesized using a 
previously reported procedure.31  H2O (10.0 mL) was added to triethylene glycol monomethyl 
ether (3.21 g, 19.5 mmol) and NaOH (1.56 g, 39.0 mmol).  Tosyl chloride (2.89 g, 20.5 mmol) 
was dissolved in THF (10.0 mL) and added dropwise over ice with stirring.  The reaction was let 
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warm to ambient temperature overnight.  Diethyl ether (20.0 mL) was then added to the reaction 
and the mixture was taken up into a separatory funnel and partitioned.  The aqueous layer was 
washed with diethyl ether (3 x 5.00 mL) then the combined organic fractions were washed with 
H2O (3 x 20.0 mL).  The organic layer was dried with anhydrous sodium sulfate, decanted and 
evaporated to dryness to give the product as a clear oil (4.08 g, 79% yield). 1H NMR (400 MHz, 
CDCl3, 25 °C): δ 7.81-7.77 (d, J = 8.3 Hz, 2H), 7.35-7.31 (d, J = 8.0 Hz, 2H), 4.17-4.13 (m, 2H), 
3.70-3.48 (br m, 10H), 3.36 (s, 3H), 2.44 (s, 3H). 
 
2-[2-(2-Methoxyethoxy)ethoxy]ethanethioacetate.  This compound was synthesized using a 
previously reported procedure.32  p-Toluenesulfonyl triethylene glycol methyl ether (3.80 g, 14.2 
mmol) and potassium thioacetate (2.02 g, 17.7 mmol) were dissolved in a round bottom flask 
containing acetone (150 mL).  A reflux condenser was added and the reaction was stirred 
vigorously overnight at 50 °C.  Solvent was removed via vacuum and the resulting mixture was 
dissolved in a biphasic mixture of 30 mL DCM and 30 mL H2O, taken up into a separatory 
funnel, and partitioned.  The aqueous layer was washed with 2 x 30 mL DCM and combined 
organics were washed with 10 mL brine.  The organic layer was dried with anhydrous sodium 
sulfate, decanted, and evaporated to dryness to give the product as a yellow oil (2.64 g, 90% 
yield).  1H NMR (400 MHz, CDCl3, 25 °C): δ 3.66-3.52 (br m, 10H), 3.37 (s, 3H), 3.09 (t, J = 6.5 
Hz, 2H), 2.33 (s, 3H). 
 
2-[2-(2-Methoxyethoxy)ethoxy]ethanethiol, mEG3SH.  This compound was synthesized using 
a previously reported procedure.33  Methanol (20.0 mL) and conc. HCl (1.50 mL) were added to 
a sealed pressure tube containing 2-[2-(2-methoxyethoxy)ethoxy]ethanethioacetate (2.06 g, 
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10.0 mmol).  The reaction mixture was stirred at 100 °C for 3 hours.  The reaction was let cool 
to ambient temperature and then H2O (20.0 mL) was added.  This mixture was extracted with 3x 
15.0 mL DCM.  Combined organic extracts were then washed with 3x 15.0 mL H2O and 1x 15 
mL brine, dried with anhydrous sodium sulfate, decanted, and evaporated to dryness to give the 
product as a yellow oil (1.37 g, 83% yield).  1H NMR (400 MHz, CDCl3, 25 °C): δ 3.68-3.53 (br 
m, 10H), 3.38 (s, 3H), 2.73-2.66 (dt, J = 8.2, 6.5 Hz, 2H), 1.58 (t, J = 8.2 Hz, 1H). 
 
p-Toluenesulfonyl tetraethylene glycol methyl ether.  The procedure for synthesis of p-
toluenesulfonyl triethylene glycol methyl ether was followed.  Tetraethylene glycol monomethyl 
ether (4.23 g) was used to prepare the product, obtained as a clear oil (4.18 g, 66% yield). 1H 
NMR (400 MHz, CDCl3, 25 °C): δ 7.83-7.76 (d, J = 8.2 Hz, 2H), 7.36-7.30 (d, J = 8.1 Hz, 2H), 
4.15 (t, J = 9.7 Hz, 2H), 3.70-3.51 (br m, 14H), 3.37 (s, 3H), 2.44 (s, 3H).  
 
2-[2-[2-(2-Methoxyethoxy)ethoxy]ethoxy]ethanethioacetate.  The procedure for synthesis of 
2-[2-(2-methoxyethoxy)ethoxy]ethanethioacetate was followed.  p-toluenesulfonyl tetraethylene 
glycol methyl ether (2.74 g) was used to prepare the product, obtained as a dark yellow oil (2.00 
g, 90% yield).  1H NMR (400 MHz, CDCl3, 25 °C): δ 3.67-3.52 (br m, 14H), 3.37 (s, 3H), 3.08 (t, 
J = 6.5 Hz, 2H), 2.33 (s, 3H). 
 
2-[2-[2-(2-Methoxyethoxy)ethoxy]ethoxy]ethanethiol, mEG4SH.  The procedure for synthesis 
of 2-[2-(2-methoxyethoxy)ethoxy]ethanethiol was followed. 2-[2-[2-(2-
methoxyethoxy)ethoxy]ethoxy]-ethanethioacetate (1.31 g) was used to prepare the product, 
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obtained as a pale yellow oil (851 mg, 78% yield).  1H NMR (400 MHz, CDCl3, 25 °C): δ 3.67-
3.49 (br m, 14H), 3.35 (s, 3H), 2.71-2.61 (m, 2H), 1.57 (t, J = 8.2 Hz, 1H). 
 
Tetraethylene glycol monotosylate.  This compound was synthesized using a previously 
reported procedure.34  Tetraethylene glycol (23.4 g, 120. mmol) was added to 100 mL round 
bottom flask and dissolved in THF (4.3 mL).  NaOH (727 mg, 18.2 mmol) was added as solution 
in 4.3 mL H2O.  Tosyl chloride (2.23 g, 12.0 mmol) was dissolved in THF (14.0 mL) and added 
dropwise over ice with stirring.  The reaction was stirred at 0 oC for 3 hours then diluted with ice 
water (70 mL).  The mixture was extracted with 3x 45 mL DCM.  The combined organic fractions 
were washed with 2 x 130 mL DI water, dried with anhydrous sodium sulfate, decanted, and 
evaporated to dryness to give the product as a pale yellow oil (3.69 g, 87% yield). 1H NMR (400 
MHz, CDCl3, 25 °C): δ 7.82-7.77 (d, J = 8.3 Hz, 2H), 7.36-7.30 (dd, J = 8.5 Hz, 0.58 Hz, 2H), 
4.16 (t, J = 4.8 Hz, 2H), 3.80-3.50 (br m, 14H), 2.44 (s, 3H) 2.17 (br s, 1H).  
 
Tetraethylene glycol monothioacetate.  The procedure for synthesis of 2-[2-(2-
methoxyethoxy)-ethoxy]ethanethioacetate was followed.  Tetraethylene glycol monotosylate 
(3.69 g) was used to prepare the product, further purification (column chromatography with 100 
% ethyl acetate) was required to obtain the product as a yellow oil (1.76 g, 57% yield).  1H NMR 
(400 MHz, CDCl3, 25 °C): δ 3.74-3.55 (br m, 14H), 3.09 (t, J = 6.5 Hz, 2H), 2.33 (s, 3H) 2.29 (br 
s, 1H). 
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1-Mercapto-11-hydroxy-3,6,9-trioxaundecane, EG4SH.  The procedure for synthesis of 2-[2-
(2-methoxyethoxy)ethoxy]ethanethiol was followed. Tetraethylene glycol monothioacetate (200 
mg) was used to prepare the product, obtained as a pale yellow oil (95 mg, 58% yield).  1H NMR 
(400 MHz, CDCl3, 25 °C): δ 3.75-3.55 (br m, 14H), 2.71-2.61 (dt, J = 8.1 Hz, J = 6.5 Hz, 2H), 
2.11 (br s, 1H), 1.62 (t, J = 8.2 Hz, 1H). 
General procedure for thiol-ene modification of GHA.  A sample of GHA (ca. 7 mg) and DMPA 
(0.2 eq per GHA residue) were placed in a 1 dram screw top vial.  THF was then added to give a 
4 mg/mL polymer concentration.  The desired thiol was then added via micropipette (3 eq per 
Hag residue) and the solution was degassed by sparging with N2 for 10 minutes.  The vial was 
then covered with parafilm and the solution was irradiated with UV light for 2.5 hours (Exo Terra 
Reptile Lamp) and let stir overnight.  The solution was then transferred to a 2000 MWCO 
dialysis bag and dialyzed against methanol for 24 hours with one change of dialysate, followed 
by dialysis in water for 24 hours with one water change.  The dialyzed polymer was lyophilized 
to dryness to give the product as a white solid. 
 
mEG3-GHA63.  The general procedure for thiol-ene modification of GHA was followed. GHA63 (6.5 
mg) and mEG3SH (3 eq per Hag residue) were used to prepare the product, obtained as a white 
solid (14.1 mg, 83% yield).  1H NMR (400 MHz, TFA-d, 25 °C): δ 4.89-4.53 (br m, 1H), 4.22-3.77 
(br m, 10H), 3.75-3.02 (br m, 5H), 3.02-2.60 (br m 2H), 2.23-1.43 (br m, 6H). 
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mEG4-GHA63.  The general procedure for thiol-ene modification of GHA was followed.  GHA63 (7.5 
mg) and mEG4SH (3 eq per Hag residue) were used to prepare the product, obtained as a white 
solid (16.3 mg, 89% yield).  1H NMR (400 MHz, TFA-d, 25 °C): δ 4.99-4.58 (br m, 1H), 4.25-3.80 
(br m, 14H), 3.80-2.55 (br m, 7H), 2.31-1.46 (br m, 6H). 
 
EG4-GHA63.  The general procedure for thiol-ene modification of GHA was followed.  GHA63 (7.5 
mg) and EG4SH (3 eq per Hag residue) were used to prepare the product, obtained as a white 
solid (16.3 mg, 89 % yield).  1H NMR (400 MHz, TFA-d, 25 °C): δ 4.95-4.50 (br m, 1H), 4.27-
3.60 (br m, 14H), 3.59-2.54 (br m, 4H), 2.20-1.43 (br m, 6H). 
 
Glc(OAc)4-GHA63.  The general procedure for thiol-ene modification of GHA was followed.  GHA63 
(10.8 mg) and 1-Thio-β-D-glucose tetraacetate (3 eq per Hag residue) were used to prepare the 
product, obtained as a white solid (38.6 mg, 84% yield).  1H NMR (400 MHz, CDCl3/TFA-d, 25 
48 
 
°C): δ 5.32 (t, J = 9.3 Hz, 1H), 5.15 (t, J = 9.6 Hz, 1H), 5.03 (t, J = 9.6, 1H), 4.59-4.48 (br d, J = 
10. Hz, 1H), 4.43 (br s, 1H), 4.24 (br s, 2H), 3.83-3.70 (br d, J = 9.8 Hz, 1H), 2.75-2.55 (br d, J = 
6.8 Hz, 2H), 2.20-1.97 (br m, 12H), 1.78-1.17 (br m, 6H). 
 
Glc-GHA63.  This deprotection follows a previously reported method that was used for a different 
glycopolymer.35  Glc(OAc)4-GHA63 (10 mg) was dissolved in 1:2 DCM:MeOH (1 mL).  An 
aqueous solution of hydrazine monohydrate (65 % (w/w), 4 eq per acetyl group) was added via 
syringe and the mixture was stirred.  Shortly after the addition of hydrazine monohydrate, a 
white precipitate formed.  The reaction was let stir overnight, after which 1-2 drops of acetone 
were added to quench excess hydrazine.  Et2O (2 mL) was added, the product was centrifuged 
at 3000 rpm, and the supernatant was discarded. The pellet was washed with ether (2 mL).  
Solvent was removed via vacuum and the product was dissolved in DI water, transferred to a 
2000 MWCO dialysis bag, and dialyzed for 48 hours with 2 water changes daily.  The dialyzed 
polymer was lyophilized to dryness to give the product as a white solid (6.2 mg, quantitative 
yield).  1H NMR (400 MHz, D2O, 25 °C): δ 4.48-4.34 (br d, J = 9.1 Hz, 1H), 3.95 (br s, 1H), 3.82-
3.71 (br d, J = 11.4 Hz, 1H), 3.66-3.54 (br m, 1H), 3.44-3.25 (br m, 3H), 3.25-3.15 (br m, 1H), 
2.67 (br s, 2H), 2.04-1.09 (br m, 6H). 
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mEG4-(rac-GHA)43.  The general procedure for thiol-ene modification of GHA was followed.  (rac-
GHA)43 (8.0 mg) and mEG3SH (6 eq per rac-Hag residue) were used to prepare the product, 
obtained as a white solid (16.3 mg, 68% yield). (93% functionalization, determined by 
comparison of alkene 2H integral (5.17 ppm) to the integral from the oligoethylene glycol group 
(4.37-3.82)).  1H NMR (400 MHz, TFA-d, 25 °C): δ 5.05-4.53 (br m, 1H), 4.37-3.82 (br m, 14H), 
3.82-2.59 (br m, 7H), 2.30-1.50 (br m, 6H). 
2.5.5 Synthesis and Modification of Diblock Copolypeptides 
Example Diblock Copolypeptide Syntheses 
 
Poly(L-methionine)50-block-poly(L-homoallylglycine)24, M50GHA24.  All polymerization 
reactions were performed in a dinitrogen filled glove box using anhydrous solvents. To a 
solution of Met NCA in THF (98.0 mg, 550 μmol, 50 mg/mL) was added a solution of Co(PMe3)4 
in THF (515 μL, 28 μmol).  Once mixed, the reaction was let stand at ambient temperature for 1 
hour and completion of polymerization was confirmed by FTIR.  An aliquot (203 μL) was 
removed from the reaction and endcapped with PEG-NCO to determine DP of the first block 
(found DP = 50) (see method above).  To the remaining polymerization solution was added a 
solution of Hag NCA in THF (39.8 mg, 2.60 μmol, 50 mg/mL).  The reaction was let stand for 1 
hour and completion of polymerization was confirmed by FTIR. The reaction was removed from 
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the glove box and 1-2 drops of 3 M HCl were added. The polypeptide was then precipitated with 
DI water, centrifuged at 3000 rpm, and the supernatant was discarded. The pellet was washed 3 
times with DI water and then lyophilized to yield poly(L-methionine)50-block-poly(L-
homoallylglycine)24, M50GHA24 (composition determined by 1H NMR), as a white solid (94.4 mg, 
99% yield).  1H NMR (400 MHz, TFA-d, 25 °C): δ 5.92-5.72 (br m, 1H), 5.19-5.05 (br m, 2H), 
5.00-4.88 (br m, 2H), 4.79-4.70 (m, 1H), 2.90-2.64 (br m, 4H), 2.40-2.13 (br m 12H), 2.10-1.90 
(br m, 2H). 
 
Poly(L-homoallylglycine)71-block-poly(L-methionine)36, GHA71M36.  All polymerization 
reactions were performed in a dinitrogen filled glove box using anhydrous solvents.  To a 
solution of Hag NCA in THF (20.1 mg, 130 μmol, 25 mg/mL) was added a solution of Co(PMe3)4 
in THF (119 μL, 6.47 μmol).  Once mixed, the reaction was let stand at ambient temperature for 
1 hour and completion of polymerization was confirmed by FTIR.  An aliquot (370 μL) was 
removed and endcapped with PEG-NCO to determine DP of the first block (found DP = 71).  To 
the remaining polymerization solution was added a solution of Met NCA in THF (6.83 mg, 39.0 
μmol, 50 mg/mL).  The reaction was let stand for 1 hour and completion of polymerization was 
confirmed by FTIR. The reaction was removed from the glove box and 1-2 drops of 3 M HCl 
were added. The polymer was then precipitated with DI water, centrifuged at 3000 rpm, and the 
supernatant was discarded. The pellet was washed 3 times with DI water and then lyophilized to 
yield Poly(L-homoallylglycine)71-block-poly(L-methionine)36, GHA71M36 (composition determined 
by 1H NMR) as a white solid (13.4 mg, 97% yield).  1H NMR (400 MHz, TFA-d, 25 °C): δ 5.92-
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5.72 (br m, 2H), 5.19-5.05 (br m, 4H), 5.00-4.88 (br m, 1H), 4.81-4.65 (br m, 2H), 2.90-2.66 (br 
m, 2H), 2.36-2.13 (br m, 9H), 2.10-1.90 (br m, 4H). 
Modifications of Diblock Copolypeptides 
 
Glc(OAc)4-GHA27M80.  GHA27M80 (14.4 mg), 1-Thio-β-D-glucose tetraacetate (8 eq per Hag 
residue) and DMPA (2.92 mg, 0.4 eq per Hag residue) were placed in a 1 dram screw top vial.  
THF was then added to give a copolymer concentration of 10 mg/mL.  The solution was then 
degassed via sparging with N2 for 10 minutes.  The vial was then covered with parafilm and the 
solution was irradiated with UV light for 2.5 hours (Exo Terra Reptile Lamp) and let stir 
overnight.  The solution was then transferred to a 2000 MWCO dialysis bag and dialyzed 
against methanol for 24 hours with one change of dialysate, followed by dialysis against water 
for 24 hours with one water change.  The dialyzed polymer was lyophilized to dryness to give 
the product as a white solid (20.4 mg, 82% yield).  1H NMR (400 MHz, CDCl3/TFA-d, 25 °C): δ 
5.34 (t, J = 9.2 Hz, 1H), 5.18 (t, J = 9.6 Hz, 1H), 5.05 (t, J = 9.6, 1H), 4.61-4.50 (br d, J = 9.6 Hz, 
1H), 4.43 (br s, 1H), 4.26 (br s, 5H), 3.83-3.70 (br d, J = 10.1 Hz, 1H), 2.80-2.47 (br m, 8H), 
2.33-2.01 (br m, 27H), 1.78-1.21 (br m, 6H). 
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Glc(OAc)4-GHA27MM80.  Glc(OAc)4-GHA27M80 (11.7 mg) was suspended in DI water (1.2 mL). 
Methyl iodide was added via syringe (6 eq per Met residue), the reaction was then covered and 
stirred vigorously for 72 hours.  The reaction mixture was transferred to a 2000 MWCO dialysis 
bag and dialyzed against 0.1 M NaCl for 24 hours, followed by DI water for 24 hours with 2 
water changes daily.  The dialyzed polymer was then lyophilized to dryness to give the product 
as a translucent white solid (13.0 mg, 95% yield).  1H NMR (400 MHz, TFA-d, 25 °C): δ 5.80-
5.59 (br m 1H), 5.58-5.41 (br m, 1H), 5.41-5.28 (br m, 1H), 5.25-4.94 (br m, 3H), 4.94-4.80 (br 
m, 1H), 4.80-4.61 (br m, 1H), 4.61-4.41 (br m, 2H), 4.19-3.98 (br m, 1H), 3.97-3.50 (br d, J = 
45.2 Hz, 6H), 3.23-3.04 (br d, J = 5.8 Hz, 18H), 2.99-2.49 (br m, 8H),  2.37-2.25 (br m, 12H), 
2.10-1.37 (br m, 6H). 
 
MO42GHA19.  A solution of hydrogen peroxide : acetic acid in DI water (3 %:1.5 % (v/v), 2.61 mL) 
was added to a vial containing M42GHA19 (31.3 mg).  The suspension was stirred vigorously 
overnight, briefly vortexed after 18 hours and let stir for 6 more hours.  The reaction was 
quenched with 1-2 drops of aqueous saturated sodium thiosulfate solution and then transferred 
to a 2000 MWCO dialysis bag.  The reaction mixture was dialyzed against water for 48 hours 
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with two water changes daily.  Lyophilization yielded the product as a white, fluffy solid (32.2 
mg, 95% yield).  1H NMR (400 MHz, TFA-d, 25 °C): δ 5.88-5.72 (br m, 1H), 5.18-5.06 (br m, 
2H), 5.05-4.86 (br m, 2H), 4.80-4.64 (br m, 1H), 3.59-3.15 (br m 5H), 3.05-2.95 (br d, J = 7.9 Hz, 
7H), 2.81-2.41 (br m , 5H), 2.34-1.89 (br m, 4H). 
 
MO42mEG4-GHA19.  MO42GHA19 (8.0 mg), and DMPA (1.9 mg, 0.4 eq per Hag residue) were placed 
in a 1 dram screw top vial.  A mixture of 25% THF in AcOH was then added to give a polymer 
concentration of 4 mg/mL. mEG4SH was then added via micropipette (10 eq per Hag residue) 
and the solution was degassed via sparging with N2 for 10 minutes.  The vial was then covered 
with parafilm and the solution was irradiated with UV light for 2.5 hours (Exo Terra Reptile 
Lamp) and let stir overnight.  The solution was then transferred to a 2000 MWCO dialysis bag 
and dialyzed against methanol for 24 hours with one change of dialysate, followed by dialysis in 
water for 24 hours with one water change.  The dialyzed polymer was lyophilized to dryness to 
give the product as a white solid (10.3 mg, 86% yield).  1H NMR (400 MHz, TFA-d, 25 °C): δ 
5.08-4.89 (br m, 2H), 4.85-4.60 (br m, 1H), 4.30-3.79 (br m, 14H), 3.76-3.22 (br m, 9H), 3.07-
3.00 (br d, J = 8.1 Hz, 6H), 2.99-2.65 (br m , 4H), 2.65-2.43 (br m, 2H), 2.18-1.49 (br m, 6H). 
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MO42mEG4-GHAM19.  MO42mEG4-GHA19 (7.7 mg) was suspended in 0.2 M formic acid (520 μL). 
Methyl iodide was added via syringe (6.6 eq per mEG4-Hag residue), the reaction was then 
covered and stirred vigorously for 72 hours.  The reaction mixture was transferred to a 2000 
MWCO dialysis bag and dialyzed against 0.1 M NaCl for 24 hours, followed by DI water for 24 
hours with 2 water changes daily.  The dialyzed polymer was then lyophilized to dryness to give 
the product as a translucent white solid (8.3 mg, 99% yield).  1H NMR (400 MHz, TFA-d, 25 °C): 
δ 5.08-4.86 (br m, 2H), 4.83-4.61 (br m, 1H), 4.24-3.80 (br m, 14H), 3.76-3.56 (br m, 5H), 3.14-
3.06 (br s, 3H), 3.04-2.97 (br d, J = 7.9 Hz, 6H), 2.83-2.63 (br m , 2H), 2.60-2.42 (br m, 2H), 
2.28-1.56 (br m, 6H). 
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Chapter 3: Synthesis of Neoglycoconjugates via Post-Polymerization 
modification of N-methylaminooxy functionalized polypeptides   
Reprinted (adapted) with permission from (Wollenberg, A.L.; Perlin, P.; Deming, T.J., Versatile 
N-methylaminooxy functionalized polypeptides for preparation of neoglycoconjugates.  
Biomacromolecules 2019, 20, 1756-1764). Copyright (2019) American Chemical Society. 
3.1 Abstract 
The preparation and characterization of a new set of well-defined polypeptides 
containing N-methylaminooxy side-chain functionality is described. These functional groups 
enabled the direct coupling of polypeptides with a variety of unmodified reducing saccharides in 
water to give neoglycopolypeptides in high yields. The use of different polypeptide scaffolds 
resulted in neoglycoconjugates with tunable chain conformations, hydrophobicity, and charge. 
These new neoglycopolypeptides were also found to be stable in aqueous media at pH 7.4 and 
37 °C for 1 week. The combination of straightforward synthesis using unmodified saccharides, 
high yields of saccharide conjugation, and conjugate stability makes these polypeptides 
attractive candidates for development of degradable glycoprotein mimics. 
3.2 Introduction 
Natural glycoproteins possess abundant biological functionality as well as structural and 
physical properties that enable their ability to provide a cellular support in the extracellular 
matrix.1 Because of the large size and complexity of glycoproteins, it is desirable to obtain 
structurally defined synthetic glycoprotein mimics for the study of cell–substrate interactions and 
for regenerative medicine biomaterial applications.2, 3 While many polymeric neoglycoconjugates 
have been reported, many rely on nonpeptidic backbones,4-6 require tedious multistep 
syntheses,7-12 or utilize chemically modified saccharide building blocks,13-16 where many are 
limited to conjugation of simple monosaccharides. To better mimic glycoproteins in biomaterial 
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applications, use of degradable peptidic polymer backbones and incorporation of complex 
oligosaccharides from natural glycoprotein components are preferred.2, 3 Further, to allow facile 
preparation of a variety of glycoprotein mimics for analysis of structure–property relationships, 
straightforward and robust synthetic methods are needed. Here, we describe the preparation of 
a new set of well-defined polypeptides containing N-methylaminooxy side-chain functionality, 
which enables direct coupling with unmodified reducing saccharides in water to give 
neoglycopolypeptides in high yields. The ability to react different saccharides to these 
polypeptides to produce a variety of stable conjugates provides a useful means for preparation 
of well-defined, highly functional neoglycoconjugates. 
There has been much recent activity toward preparation of neoglycopolypeptides. These 
methods are based on two strategies: (i) ring-opening polymerization of glycosylated amino acid 
N-carboxyanhydride (NCA) monomers7-12 or (ii) post-polymerization conjugation of saccharides 
to reactive precursor polypeptides.13-16 Both of these methods are able to provide polypeptides 
with high degrees of glycosylation, and many examples have been reviewed. The glycosylated 
NCA route provides advantages of 100% saccharide functionalization and the ability to utilize 
natural glycoside linkages (e.g., to serine residues). The main disadvantage of this method is 
the need for multistep monomer synthesis, use of protecting groups, and tedious monomer 
purification. Consequently, use of this methodology for incorporation of complex 
oligosaccharides containing additional functionality, for example, sulfonate and carboxylate 
groups often present in glycoproteins, is challenging. Post-polymerization neoglycoconjugate 
formation offers the advantage of simple and often more readily prepared polypeptide chains 
but conjugations can suffer from incomplete saccharide functionalization.13-16 Most of the 
reported methods also require use of saccharides that have been modified to contain reactive 
functionality, such as azide, alkyne, thiol, epoxide, alkyl halide, or isothiocyanate groups.13-16 
These modifications require additional synthetic steps, and also result in incorporation of 
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unnatural linkages such as triazole groups into the neoglycoconjugates that may affect 
biological properties. 
On the basis of these studies, we sought to develop a facile method for 
neoglycopolypeptide synthesis utilizing a post-polymerization conjugation strategy, but wanted 
to improve conjugation to allow incorporation of more complex saccharides, and remove the 
need for saccharide chemical modification. Our strategy was focused on use of the oxime 
ligation,17, 18 a chemoselective and efficient method that has been used in many different 
polymer systems for post-polymerization functionalization, including neoglycoconjugate 
formation.4-6, 19-21 While oxime ligation has not been used to prepare neoglycopolypeptides,22 it 
has been utilized to prepare neoglycoconjugates in short peptide and peptoid sequences.23-26 A 
significant advantage in the use of aminooxy-functionalized peptides and polymers is their ability 
to react directly with unmodified reducing saccharides. Another important feature is that while 
saccharide conjugation to aminooxy groups typically results in ring-opened saccharides, the use 
of N-alkylaminooxy or N-alkoxyamino groups results in ring closed saccharide conjugates that 
better mimic natural glycan presentation.27 Using this knowledge, Godula’s laboratory recently 
showed that N-methylaminooxy-functionalized polyacrylamides can be used to prepare 
neoglycoconjugates with a variety of unmodified complex oligosaccharides derived from 
glycoproteins.4-6 Here, we build upon this work by development of new water-soluble 
polypeptides containing side-chain N-methylaminooxy functionality. The conjugation of 
saccharides to these polypeptides was evaluated, and physical properties of 
neoglycoconjugates with different side-chain structures were compared. These new 
polypeptides were found to enable straightforward preparation of neoglycopolypeptides with 
high degrees of saccharide conjugation in aqueous media. 
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3.3 Results and Discussion 
A N-methylaminooxy-functionalized amino acid derived from L-homoserine has been 
previously reported for preparation of neoglycoconjugates in peptides.24, 25 While this residue 
may be amenable for polypeptide synthesis, we initially chose to develop a new N-
methylaminooxy-functionalized derivative of L-homocysteine because previous work suggests 
that the resulting polypeptide would possess good solubility during polymerization, and the side-
chain thioether groups would allow further modification by oxidation or alkylation to adjust 
polymer properties.28 The target 2-(N-Boc-N-methylaminooxy)ethyl-L-homocysteine amino acid 
was prepared in two steps from readily available L-methionine in high yield.  Subsequent 
phosgenation in the presence of acid scavengers gave the desired monomer, 2-(N-Boc-N-
methylaminooxy)ethyl-L-homocysteine NCA, Boc-mao-Ehc NCA, as an oil that was purified by 
chromatography on dried silica (Figure 3.1).29  
 
Figure 3.1 Synthesis of Boc-mao-Ehc NCA. 
Boc-mao-Ehc NCA was found to polymerize readily in THF to complete monomer 
conversion using Co(PMe3)4 initiator (Figure 3.2).30 Homopolypeptide chain lengths were 
controlled by adjustment of monomer to initiator ratios enabling preparation of poly(2-(N-Boc-N-
methylaminooxy)ethyl-L-homocysteine)n, Boc-mao-Ehcn, with degrees of polymerization up to 
145 with low dispersity (Figure 3.3). Subsequent deprotection of a model sample, Boc-mao-
Ehc70, under a variety of acidic conditions was found to yield only intractable cross-linked solids. 
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Figure 3.2 Synthesis of mao-EhcO70 and mao-EhcM70. 
 
Figure 3.3 Molecular weight (Mn, circles) and dispersity (Mw/Mn, squares) of Boc-mao-Ehcn as 
a function of monomer to initiator ratio ([M]/[I]) using (PMe3)4Co in THF at 20 °C. Mn values were 
calculated via end group analysis using 1H NMR integrations, and GPC/MALS was utilized to 
determine Mw/Mn. 
We suspect that protonation of free N-methylaminooxy groups formed during acidic 
deprotection results in sulfur mustard type chemistry where N-methylhydroxylamine can 
eliminate, yielding electrophilic cyclic sulfonium intermediates that can be attacked by N-
methylaminooxy groups of other chains to give crosslinks (Figure 3.4).31  
62 
 
 
Figure 3.4 Possible crosslinking side reaction during TFA deprotection of Boc-mao-Ehc70. 
 
Figure 3.5 1H NMR spectra overlay of A) Boc-mao-Ehc70 B) Boc-mao-EhcO70 and C) mao-
EhcO70. 
To circumvent this issue, Boc-mao-Ehc70 was first oxidized or methylated before 
deprotection to give the more polar derivatives poly(2-(N-Boc-N-methylaminooxy)ethyl-L-
homocysteine sulfoxide)70, Boc-mao-EhcO70, or poly(2-(N-Boc-N-methylaminooxy)ethyl-L-
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homocysteine methyl sulfonium)70, Boc-mao-EhcM70, respectively (Figure 3.2, Figure 3.5, 
Figure 3.6). 
 
Figure 3.6 1H NMR spectra overlay of A) Boc-mao-Ehc70 B) Boc-mao-EhcM70 and C) mao-
EhcM70. 
Both of these reactions gave essentially quantitative modifications of the parent thioether 
groups, similar to previously described results on related polypeptides.28 Subsequent 
deprotection of Boc-mao-EhcO70 and Boc-mao-EhcM70 using trifluoroacetic acid gave the 
desired water-soluble, N-methylaminooxy-functionalized poly(2-(N-methylaminooxy)ethyl-L-
homocysteine sulfoxide)70, mao-EhcO70, and poly(2-(N-methylaminooxy)ethyl-L-homocysteine 
methyl sulfonium)70, mao-EhcM70, without cross-linking (Figure 3.2, Figure 3.5, Figure 3.6). 
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With these N-methylaminooxy-functionalized polypeptides in hand, one nonionic and 
one cationic, we also prepared a homologous polypeptide using a different synthetic route. This 
target polypeptide, poly((6-(2-N-methylaminooxy)ethylthio)-L-norleucine sulfoxide)70, mao-
EtnO70, was prepared by coupling poly(L-homoallylglycine)70, GHA70, with a N-methylaminooxy 
containing thiol, followed by oxidation and deprotection as described above (Figure 3.7, Figure 
3.8, Figure 3.9).32 
 
Figure 3.7 Synthesis of 2-(N-Boc-N-methylaminooxy)ethyl mercaptan. 
 
Figure 3.8 Synthesis of mao-EtnO70. 
In mao-EtnO70, the terminal N-methylaminooxy groups are two additional methylenes 
further from the polypeptide backbone compared with mao-EhcO70. This difference was 
expected to lead to greater side-chain hydrophobicity and α-helical conformational stability in 
water for mao-EtnO70. To compare aqueous solution properties of these polypeptides, they were 
analyzed using CD spectroscopy. 
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Figure 3.9 1H NMR spectra overlay of A) GHA70, B) Boc-mao-Etn70, C) Boc-mao-EtnO70, and D) 
mao-EtnO70. 
First, mao-EhcO70 solutions were prepared in aqueous buffers ranging in pH from 2 to 9. 
Analysis of these solutions using CD spectroscopy showed that the chains primarily adopt 
disordered conformations across this pH range, yet a subtle change occurs between pH 3 and 4 
where the chains appear to adopt a partial α-helical conformation above pH 4 (Figure 3.10A).33 
Measurement of zeta potential for solutions of mao-EhcO70 as a function of pH revealed a 
transition from positive to slightly negative values between pH 3 and 5, indicative of a change 
from protonated to nonprotonated N-methylaminooxy groups over this pH range (Figure 3.10B). 
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This transition correlates well with the expected pKa range of N-methylaminooxy groups (ca. 
3.65–4.75)34 and was corroborated by analysis of other control samples that included nonionic 
poly(L-methionine sulfoxide) (MO70), pH invariant cationic poly(S-methyl-L-methionine sulfonium) 
(MM70), and poly(L-lysine·HCl)70 (K70) that undergoes a cationic to uncharged transition at a 
much higher pH (pKa ca. 9–10) (3.10B).28, 35 These results suggest that mao-EhcO70 is 
uncharged above pH ~ 5 where it also retains good water solubility, which contrasts sharply with 
K70 that precipitates readily upon neutralization. 
 
Figure 3.10 (A) CD spectra of mao-EhcO70 at 20 °C and 0.1 mg/mL concentration in aqueous 
buffers containing 100 mM phosphate and 10 mM Tris adjusted to pH 2 (black), 3 (green), 4 
(purple), 5 (blue), or 9 (red) using HCl (0.1 M) or NaOH (0.1 M). (B) Zeta potentials as a function 
of pH for aqueous solutions of mao-EhcO70 (red circles), MO70 (black squares), MM70 (purple 
down triangles), and K70 (blue up triangles). * = K70 was observed to precipitate above pH 11. 
To further analyze the chain conformation of uncharged mao-Ehc
O
70
, CD analysis was 
performed in water containing NaOH and increasing concentrations of methanol. As the 
methanol fraction increased, chains transitioned to α-helical conformations, up to a plateau of 
ca. 60% helicity (Figure 3.11). Increased α-helical content in methanol likely reflects the weaker 
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solvation of sulfoxide groups by this solvent compared with water, which is known to bind 
sulfoxides strongly and disrupt H-bonding as previously observed in M
O
 polypeptides.28  
 
Figure 3.11 A) Circular dichroism spectra of mao-EhcO70 dissolved in aqueous solvent mixtures 
containing NaOH and methanol. Concentrations of methanol ranged from 0 to 80 volume %, 
and concentration of NaOH was 2 x 10-5 M. B) The α-helical content (% helicity) as a function of 
methanol content was calculated using molar ellipticity values at 222 nm from the circular 
dichroism spectra in A.  
To evaluate how the side-chain length affects properties, a CD spectrum of mao-EtnO70 
was collected at pH 2 for comparison to data obtained under identical conditions for mao-
EhcO70. At this pH, mao-EtnO70 displays higher α-helical content compared with mao-EhcO70 
likely because of its longer hydrophobic tether (Figure 3.12). However, the increased 
hydrophobicity of mao-EtnO70 also impacts solubility such that it only possesses good water 
solubility in its protonated form below pH of ca. 4–5. CD spectroscopy was also used to study 
the conformation of cationic mao-EhcM70. Because this polypeptide is charged independent of 
pH, it was found to always adopt a disordered conformation similar to most highly charged 
polypeptides in water (Figure 3.13).28 
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Figure 3.12 Circular dichroism spectra of mao-EhcO70 (black) and mao-EtnO70 (red) at pH 2.  All 
polypeptides were dissolved in an aqueous buffer containing 100 mM phosphate and 10 mM 
Tris, and the pH was adjusted using 0.1 M HCl. 
 
Figure 3.13 Circular dichroism spectrum of mao-EhcM70 at 20 oC and 0.1 mg/mL concentration 
in aqueous buffer containing 100 mM phosphate and 10 mM Tris adjusted to pH 5 using HCl 
(0.1 M). 
The three N-methylaminooxy-functionalized polypeptides were next evaluated for their 
ability to conjugate a model monosaccharide, D-glucose, under different conditions. First, 
nonionic sulfoxide containing mao-EhcO70 and mao-EtnO70 were reacted with D-glucose in the 
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presence of aniline catalyst in water,36, 37 where pH, D-glucose concentration, and temperature 
were varied (Figure 3.14). 
 
 
Figure 3.14 Isolated and saccharide conjugation yields for reactions of mao-EhcO70 (n = 2) or 
mao-EtnO70 (n = 4) with D-glucose. Experiments with mao-EtnO70 were performed at lower 
polypeptide concentrations due to low solubility. All reaction conditions as shown in Eq 4, except 
* = without aniline.  Reaction conditions shown in equation. 
Entries 1–4 and 13–16 in Figure 3.14 show that pH had little effect on saccharide 
conjugation yields after 4 days for mao-EhcO70, and a modest effect on yields with mao-EtnO70 
possibly because of the diminished solubility of this polypeptide at higher pH.  Although lower 
pH accelerates the coupling reaction, it also accelerates the hydrolysis of the product, leading to 
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equilibrium levels of saccharide conjugation that are less than quantitative. As such, we found it 
useful to perform conjugations mainly at pH 7 to disfavor hydrolysis of the neoglycoconjugates 
and obtain high levels of saccharide functionalization (ca. 80–90%).27, 38 As a control experiment 
to highlight the significance of the N-methylaminooxy functionality for neoglycoconjugate 
formation, attempts were also made to conjugate D-glucose to poly(L-lysine·HCl)
70
 under similar 
conditions. For all conditions attempted, no glycoconjugate formation was observed for poly(L-
lysine·HCl)
70
, showing that glycoconjugation is selectively efficient for N-methylaminooxy 
functionality (Figure 3.15). 
 
Aniline (0.1 M) pH 
Saccharide 
Conjugation (%) 
Yield 
(%) 
- 5 0 99 
+ 7 0 96 
Figure 3.15 Isolated and saccharide conjugation yields for reactions of poly(L-lysine·HCl)70, K70, 
with D-glucose.  Reaction conditions shown in equation. 
At pH 7, saccharide conjugation is slow even in the presence of aniline, so the 
equivalents of D-glucose per N-methylaminooxy group were increased from 5 to 500 (Entries 5-
8 and 17-18). A large excess of glucose was found to give high levels of saccharide conjugation 
for both mao-EhcO70 and mao-EtnO70, although this strategy may not be practical for 
conjugation of expensive saccharides. Changing the temperature of mao-EhcO70 conjugations 
from 25 to 50 °C was also found to be an effective way to increase saccharide conjugation 
yields when using fewer equivalents of D-glucose (Entries 9-12), and may be a better strategy 
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for conjugation of expensive saccharides. For comparison to the non-ionic polypeptides 
discussed above, cationic mao-EhcM70 was also reacted with D-glucose under a select set of 
conditions (Figure 3.16). At pH 7, significantly lower saccharide conjugation to mao-EhcM70 
(37%) was observed under identical conditions used for mao-EhcO70 (89%; Figure 3.15, Entry 
7). However, at pH 5 with aniline catalyst, high levels of saccharide conjugation to mao-EhcM70 
(93%) were readily obtained. 
 
Aniline 
Buffer 
(pH) 
Saccharide 
Conjugation (%) 
Yield 
(%) 
- 5 47 99 
+ 5 93 93 
+ 7 37 91 
Figure 3.16 Isolated and saccharide conjugation yields for reactions of mao-EhcM70 with D-
glucose. Reaction conditions shown in equation. 
To evaluate physical properties of the neoglycopolypeptide conjugates, Glc-mao-EhcO70 
and Glc-mao-EtnO70 were chosen as model samples for CD spectroscopy analysis. CD spectra 
of Glc-mao-EhcO70 collected at pH 5 and 9 were nearly identical (Figure 3.17A) and suggest 
that this polypeptide adopts highly disordered conformations over this pH range. Increased 
solvation of this glucose-functionalized polypeptide in water as compared to mao-EhcO70 may 
explain the loss of partial α-helical content observed in the parent sample. CD spectra of Glc-
mao-EtnO70 collected at pH 5 and 9 showed that this polypeptide also adopted partial α-helical 
conformations with the helical content increasing with pH (Figure 3.17B).33 The longer 
hydrophobic tether in Glc-mao-EtnO70 likely helps to stabilize the α-helical conformation in these 
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polypeptides despite the addition of polar glucose groups. As expected for a polyelectrolyte, 
cationic Glc-mao-EhcM70 was found to be disordered between pH 5 and 9, similar to parent 
mao-EhcM70 (Figure 3.18).39 
 
Figure 3.17 CD spectra of (A) Glc-mao-EhcO70 and (B) Glc-mao-EtnO70 at 20 °C. Samples 
were prepared at 0.1 mg/mL concentration in aqueous buffers containing 100 mM phosphate 
and 10 mM Tris adjusted to pH 2 (black), 5 (blue), or 9 (red) using HCl (0.1 M) or NaOH (0.1 M). 
 
Figure 3.18 Circular dichroism spectra of glc-mao-EhcM70 at 20 °C and 0.1 mg/mL 
concentration in aqueous buffers containing 100 mM phosphate and 10 mM Tris adjusted to pH 
2 (black), 5 (blue), or 9 (red) using HCl (0.1 M) or NaOH (0.1 M). 
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 Stability of model neoglycoconjugates at different pH in water was also evaluated. 
Aqueous solutions of Glc-mao-EhcO70, Glc-mao-EtnO70, and Glc-mao-EhcM70 (all greater than 
90% glycosylation) were individually dialyzed at 37 °C for 1 week at pH of either 5.5 or 7.4 
(Figure 3.19). Subsequent analysis of the samples by 1H NMR was used to quantify the loss of 
D-glucose from each sample. 
 
Figure 3.19 Release of free D-glucose from Glc-mao-EhcO70 (black), Glc-mao-EtnO70 (gray) 
and Glc-mao-EhcM70 (white) at pH 5.5 (200 mM phosphate) and 7.4 (200 mM phosphate). All 
samples were incubated at 37 °C for 1 week. Error bars are consistent with standard deviations 
of n = 3. 
Because acid is known to catalyze both glycoconjugate formation and hydrolysis, and 
free D-glucose was removed during reactions, all samples were partially deglycosylated at pH 
5.5.40 Although the degree of deglycosylation (ca. 30–40%) was comparable for these samples, 
the more polar Glc-mao-EhcO70 showed greater loss of D-glucose compare with less polar Glc-
mao-EtnO70. The cationic neoglycoconjugate Glc-mao-EhcM70 was also found to be more stable 
at pH 5.5 compared with Glc-mao-EhcO70, where the nearby cationic sulfonium group in Glc-
mao-EhcM70 may be hindering N-glycoside protonation, which is the first step in hydrolysis. All 
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three samples showed high neoglycoconjugate stability at pH 7 for 1 week at 37 °C, which 
makes them promising for use in downstream biological studies. 
3.4 Conclusion 
A set of N-methylaminooxy-functionalized polypeptides has been prepared and 
characterized. These new functional polypeptides are water soluble and were found to react 
with unmodified reducing saccharides to form neoglycoconjugates in high yields under a variety 
of aqueous conditions. While N-methylaminooxy-functionalized and related polymers have been 
reported, this approach has not been previously demonstrated in synthetic polypeptides. The 
variation of polypeptide scaffolds resulted in neoglycoconjugates with different chain 
conformations, hydrophobicity, and charge. The combination of straightforward synthesis, high 
yields of saccharide conjugation, and conjugate stability makes these polypeptides attractive 
candidates for use as degradable glycoprotein mimics. 
3.5 Experimental 
3.5.1 Materials and Methods 
THF, hexanes, and DCM were dried by purging with nitrogen and passage through 
activated alumina columns prior to use. TEA and TMSCl were purified by distillation and stored 
over 3 Å molecular sieves. Co(PMe3)4, L-methionine NCA, and Nε-Z-L-lysine NCA monomers 
were prepared according to literature procedures.29, 30, 35 Poly(L-methionine sulfoxide)70 (MO70), 
poly(S-methyl-L-methionine sulfonium)70 (MM70), and poly(L-lysine·HCl)70 (K70) were prepared 
according to literature procedures.39, 41 All other chemicals were purchased from commercial 
suppliers and used without further purification unless otherwise noted. Selecto silica gel 60 
(particle size 0.032– 0.063 μm) was used for flash column chromatography. FTIR 
measurements were taken using a Perkin Elmer RX1 FTIR calibrated using polystyrene film. 1H 
NMR spectra were acquired on a Bruker ARX 400 spectrometer. GPC/MALS was performed at  
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25 °C using an SSI Accuflow Series III pump equipped with Wyatt DAWN EOS light scattering 
and Optilab REX refractive index detectors. Separations were achieved using 100 Å and 1000 Å 
PSS-PFG 7 µm columns at 30 °C with 0.5% (w/w) KTFA in HFIP as eluent and sample 
concentrations of 10 mg/mL. Zeta potential data were collected using a Zetasizer NanoZS.  
Samples of mao-EhcO70, MO70, MM70, and K70 were dissolved at 5–15 mg/mL in filtered (0.45 
μm) water containing 20 mM NaCl. Polypeptide solutions were adjusted to pH 2.0 using filtered 
(0.45 μm) aqueous 1.0 M HCl. The solutions were titrated to pH 12 with filtered (0.45 μm) 
aqueous 1.0 M NaOH. Aliquots (1 mL) were removed from the solutions at specific pH values.  
Pyrogen free DI water was obtained from a Millipore Milli-Q Biocel A10 purification unit. Dialysis 
was conducted using regenerated cellulose dialysis tubing (Spectrum Labs, MWCO 2000 Da). 
All CD spectra were collected using an OLIS RSM CD spectrophotometer (OLIS, USA) using 
conventional scanning mode. Samples were characterized by recording spectra (185-260 nm) 
within a quartz cuvette of 0.1 cm path length.  Samples of mao-EhcO70, mao-EhcM70, mao-
EtnO70, glc-mao-EhcO70, glc-mao-EhcM70 and glc-mao-EtnO70 were prepared at concentrations 
of 0.1 mg/mL in aqueous buffers containing 100 mM phosphate and 10 mM Tris. The buffered 
solutions were adjusted to pH 2.0, 3.0, 4.0, 5.0, and 9.0 using HCl (0.1 M) or NaOH (0.1 M).  
Percent α-helical content of polypeptides was estimated using the formula % α-helix = 100 × 
(−[θ]222 + 3000)/39000), where [θ]222 is the measured molar ellipticity at 222 nm.  Mass 
spectrometry data was obtained by dissolving the sample in acetonitrile (50 ng/mL) and analysis 
in negative mode using a Q Exactive Plus hybrid quadrupole-Orbitrap mass spectrometer with 
Dionex Ultimate 3000 RSLCnano System. Resolving power was 70,000 at m/z 200. Multiple 
spectra (50) were averaged to improve signal to noise. 
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3.5.2 Synthesis of small molecules 
 
N-Boc-N-methylhydroxylamine.26  Sodium bicarbonate (10.9 g, 130 mmol, 2.3 eq) was slowly 
added to a stirring mixture of N-methylhydroxylamine hydrochloride (6.00 g, 72 mmol, 1.3 eq) in 
DI water (78 mL) and methylene chloride (60 mL). The reaction was cooled in an ice bath and di-
tert-butyl dicarbonate (12.50 g, 57 mmol, 1.0 eq) was slowly added. The reaction was allowed to 
come to room temperature and stirred for 16 hours. It was then quenched with concentrated 
sodium bicarbonate in water (18 mL). The product was extracted from water (100 mL) using 4 x 
ethyl acetate (100 mL). The organic fractions were combined and dried with anhydrous sodium 
sulfate followed by concentration under reduced pressure to yield a yellow oil. The crude product 
was further purified using column chromatography (10% ethyl acetate/hexanes to 30% ethyl 
acetate/hexanes) to give a colorless oil (7.08 g, 83.9% yield).  1H NMR (400 MHz, CDCl3, 25 °C): 
δ 3.15 (s, 3H), 1.46 (s, 9H). 13C NMR (100 MHz, CDCl3, 25 °C): δ 157, 81.9, 37.9, 28.4. 
 
2-(N-Boc-N-methylaminooxy)ethyl bromide.  Adapted from a procedure for synthesis of the 
unsubstituted aminooxy derivative.42 DBU (4.05 mL, 27 mmol, 1.0 eq) was slowly added to a 
solution of N-Boc-N-methylhydroxylamine (4.00 g, 27 mmol, 1.0 eq) in 1,2-dibromoethane (16.8 
mL). The reaction was allowed to stir at ambient temperature for 16 hours and went from a clear 
colorless solution to a yellow suspension. The product was extracted from water (200 mL) using 
4 x ethyl acetate (200 mL). Organic fractions were combined and dried with anhydrous sodium 
sulfate followed by concentration under reduced pressure to yield a yellow oil. The crude 
product was further purified using column chromatography (15% ethyl acetate/hexanes) to give 
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a yellow oil. Finally, the product was vacuum distilled to yield a colorless oil (3.51 g, 50.8% 
yield). 1H NMR (400 MHz, CDCl3, 25 °C): δ 4.13 (t, J = 6.3 Hz, 2H), 3.51 (t, J = 6.3 Hz, 2H), 
3.11 (s, 3H), 1.49 (s, 9H). 13C NMR (100 MHz, CDCl3, 25 °C): δ 157, 81.9, 74.1, 37.5, 28.4, 
28.39. 
 
2-(N-Boc-N-methylaminooxy)ethyl-L-homocysteine.  Synthesis of the L-homocysteine 
derivative was accomplished by adapting a procedure from literature.43 L-methionine (0.94 g, 6 
mmol, 1.0 eq) was dissolved in liquid ammonia (30 mL) and sodium metal (0.57 g, 24 mmol, 4.0 
eq) was added in small pieces until the solution was heterogeneous and a blue color persisted 
for 15 minutes. The blue color was then quenched by adding ammonium chloride (1.0 g, 42 
mmol, 7 eq) until the reaction mixture was colorless and homogenous. At this point, tert-Butyl 2-
bromoethoxy(methyl)carbamate (1.59 g, 6 mmol, 1.0 eq) was slowly added and the reaction 
was allowed to stir for 1 hour. The ammonia was removed under reduced pressure to yield a 
crude white solid. The white solid was dissolved in a minimal amount of DI water (15 mL) and 3 
M HCl (5 mL) was added until the pH was between 6 and 7. The water was removed under 
reduced pressure to yield a crude white solid which was contaminated with salt (60% salt wt/wt) 
and used without further purification (5.75 g (2.30 g without salt), 100% yield). 1H NMR (400 
MHz, D2O, 25 °C): δ 4.15 (t, J = 6.2 Hz, 2H), 3.93 (dd, J = 7.0, 5.5 Hz, 1H), 3.23 (s, 3H), 2.92 (t, 
J = 6.2 Hz, 2H), 2.80 (t, J = 7.6 Hz, 2H), 2.32-2.14 (m, 2H), 1.56, (s, 9H). 13C NMR (100 MHz, 
D2O, 25 °C): 174, 157, 83.8, 72.7, 53.9, 35.9, 30.4, 29.1, 27.6, 27.2. 
 
 
78 
 
 
2-(N-Boc-N-methylaminooxy)ethyl-L-homocysteine N-carboxyanhydride, Boc-mao-Ehc 
NCA.  To a solution of crude 2-(N-Boc-N-methylaminooxy)ethyl-L-homocysteine (3.0 g (ca. 1.2 
g amino acid), 3.3 mmol, 1.0 eq) in dry THF (30 mL) in a Schlenk flask was added TEA (0.92 
mL, 6.6 mmol, 2.0 eq) and TMSCl (0.84 mL, 6.6 mmol, 2.0 eq) via syringe. The reaction was 
stirred under N2 at room temperature for 1 hour. Upon addition of TEA and TMSCl, precipitation 
of TEA·HCl was observed. A solution of 15% (w/v) phosgene in toluene (4.7 mL, 6.6 mmol, 2.0 
eq) was then added via syringe and the reaction was stirred under N2 at 50 °C for 2 hours. 
Caution! Phosgene is extremely hazardous and all manipulations must be performed in a well-
ventilated chemical fume hood with proper personal protection and necessary precautions taken 
to avoid exposure.  After 2 hours, the reaction was cooled and evaporated to dryness then 
transferred into a N2 filled glovebox. In the fume hood, the condensate in the Schlenk line 
vacuum traps was treated with 50 mL of concentrated aqueous NH4OH to neutralize residual 
phosgene.  In the glove box, THF was added to the crude product and the insoluble salts were 
removed by vacuum filtration and were washed with THF. The filtrate was evaporated under 
reduced pressure to yield an orange/red oil that was purified by passing it through vacuum dried 
silica using 10% THF/hexanes to 30% THF/hexanes.29 Fractions containing the NCA were 
combined and concentrated under reduced pressure to yield a pale yellow oil (0.73 g, 67% 
yield). 1H NMR (400 MHz, CDCl3, 25 °C): δ 7.58-7.46 (bs, 1H), 4.57 (ddd, J = 9.2, 4.1, 0.8 Hz, 
1H), 4.10 (m, 1H), 4.01 (m, 1H), 3.12 (s, 3H), 2.92 (m, 2H), 2.74 (t, J = 5.6 Hz, 2H), 2.22 (m, 
1H), 2.06 (m, 1H), 1.50 (s, 9H).  13C NMR (100 MHz, CDCl3, 25 °C): δ 170, 157, 152, 82.6, 
74.1, 56.3, 36.9, 31.3, 29.9, 28.4, 28.1. FTIR: NCA bands at 1857, 1787 and Boc bands at 1730 
and 1705 cm-1. MS m/z = 333.1128 [M-H]- (calcd 333.1120 for C13H21O6N2S). 
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2-(N-Boc-N-methylaminooxy)ethanol.  Adapted from a procedure for synthesis of the 
unsubstituted aminooxy derivative.44 N-Boc-N-methylhydroxylamine (6.45 g, 44 mmol, 1.0 eq) 
and 2-bromoethanol (9.23 mL, 130 mmol, 3.0 eq) were dissolved in dry DCM (50 mL).  The 
solution was cooled in an ice bath and then DBU was added dropwise (6.51 mL, 44 mmol, 1.0 
eq).  The reaction was allowed to come to room temperature and was stirred for 72 hours.  50 
mL DCM was added to the reaction mixture and the resulting solution was washed with DI water 
(3 x 80 mL).  The organic layer was dried with anhydrous sodium sulfate, decanted and 
evaporated to dryness.  The crude residue was purified by column chromatography using 7:3 
hexane:ethyl acetate until elution of the product began, then 1:1 hexane:ethyl acetate until 
product had eluted.  The fractions were evaporated to dryness to give a clear oil (3.14 g, 38% 
yield).  1H NMR (400 MHz, CDCl3, 25 °C): δ 3.89 (sext, J =1.8, 2H), 3.76-3.42 (br m, 3H), 3.09 
(s, 3H), 1.49 (s, 9H).  13C NMR (100 MHz, CDCl3, 25 °C): δ 158, 82.3, 75.4, 59.5, 36.6, 28.2. 
 
2-(N-Boc-N-methylaminooxy)ethyl tosylate.  Adapted from a procedure for synthesis of a 
related molecule.45 A solution of NaOH (1.23 g, 31 mmol, 2.7 eq) in DI water (15 mL) was added 
to a flask containing 2-(N-Boc-N-methylaminooxy)ethanol (2.83 g, 15 mmol, 1.3 eq).  Tosyl 
chloride (2.19 g, 12 mmol, 1.0 eq) was dissolved in THF (15 mL) and added dropwise at 0 °C.  
The reaction was allowed to come to room temperature overnight.  Ether was then added (30 
mL) and the reaction mixture was partitioned.  The aqueous layer was washed with ether (3 x10 
mL) and the combined organics were washed with DI water (3 x 30 mL).  The organic layer was 
dried with anhydrous sodium sulfate, decanted and evaporated to dryness.  The crude residue 
was purified by column chromatography using 7:3 hexane:ethyl acetate.  The desired fractions 
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were combined and evaporated to dryness to give the product as a clear oil (4.37 g, 74% yield). 
1H NMR (400 MHz, CDCl3, 25 °C): δ 7.83-7.77 (m, 2H), 7.35 (d, J = 8.0 Hz, 2H), 4.21 (q, J = 3.1 
Hz, 2H), 4.03 (q, J = 3.1 Hz, 2H), 3.01 (s, 3H), 2.45 (s, 3H), 1.46 (s, 9H).  13C NMR (100 MHz, 
CDCl3, 25 °C): δ 157, 145, 133, 130, 128, 81.8, 71.7, 67.2, 37.3, 28.2, 21.6. 
 
S-(2-(N-Boc-N-methylaminooxy)ethyl) ethanethioacetate.  Adapted from a procedure for 
synthesis of a related molecule.46 2-(N-Boc-N-methylaminooxy)ethyl tosylate (3.03 g, 9 mmol, 
1.0 eq) was dissolved in acetone (140 mL).  Potassium thioacetate (1.47 g, 13 mmol, 1.4 eq) 
was added to the resulting solution.  A condenser was placed on the flask and the reaction was 
let stir at 50 °C overnight.  Acetone was then removed via vacuum and DCM (35 mL) and water 
(35 mL) was used to transfer the crude residue to a separatory funnel.  The aqueous layer was 
washed with DCM (2 x 35 mL) and the combined organics were washed with brine.  The organic 
layer was dried with anhydrous sodium sulfate, decanted and evaporated to dryness to give the 
product as a yellow oil (2.19 g, 86% yield).  1H NMR (400 MHz, CDCl3, 25 °C): δ 3.95 (t, J = 6.3 
Hz, 2H), 3.13 (t, J = 6.3 Hz, 2H), 3.08 (s, 3H), 2.34 (s, 3H), 1.49 (s, 9H).  13C NMR (100 MHz, 
CDCl3, 25 °C): δ 195, 157, 81.5, 72.6, 37.0, 30.5, 28.3, 27.4. 
 
2-(N-Boc-N-methylaminooxy)ethyl mercaptan.  Adapted from a procedure for deprotection of 
a related molecule.47 A solution of S-(2-(N-Boc-N-methylaminooxy)ethyl) ethanethioacetate 
(1.12 g, 5 mmol, 1.0 eq) in methanol (20 mL) was degassed for 30 minutes via sparging with N2. 
NaOMe in methanol (30 wt%) was then added via syringe (2.51 mL, 11 mmol, 2.2 eq).  The 
reaction was let stir under nitrogen atmosphere for 1 hour, after which degassed acetic acid was 
added (0.92 mL).  The reaction mixture was diluted with DI water (60 mL), transferred to a 
separatory funnel and extracted with DCM (4 x 50 mL).  The organic layer was dried with 
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anhydrous sodium sulfate, decanted and evaporated to dryness to give the product as a yellow 
oil (0.819 g, 88% yield). 1H NMR (400 MHz, CDCl3, 25 °C): δ 3.96 (t, J = 6.5, 2H), 3.10 (s, 3H), 
2.73 (sext, J = 4.23, 2H), 1.65 (t, J = 8.3, 1H), 1.49 (s, 9H).  13C NMR (100 MHz, CDCl3, 25 °C): 
δ 157, 81.6, 75.7, 37.0, 28.3, 22.7. 
3.5.3 Synthesis of mao-EhcO70, mao-EhcM70, and mao-EtnO70 
 
poly(2-(N-Boc-N-methylaminooxy)ethyl-L-homocysteine)70, Boc-mao-Ehc70.  All 
polymerization reactions were performed in a N2 filled glove box using anhydrous THF. To 
prepare Boc-mao-Ehc70 at ca. 100 mg scale, a solution of Co(PMe3)4 (3.6 mg, 0.010 mmol, 1.0 
eq) in THF (20 mg/mL) was quickly added to a solution of Boc-mao-Ehc NCA (100 mg, 0.30 
mmol, 30 eq) in THF (50 mg/mL) at 20 °C. After ca. 60 minutes, complete consumption of NCA 
was confirmed by FTIR spectroscopy. In order to determine the length of Boc-mao-Ehc70, a 
small aliquot (200 µL) of the polymerization mixture was removed for end-group analysis (see 
SI). The reaction mixture was then removed from the glove box and the polypeptide was 
precipitated into DI water (100 mL), collected using centrifugation, and dried under reduced 
pressure to yield an off white solid with yields ranging from 85 to 90%. 1H NMR (400 MHz, TFA-
d, 25 °C): δ 4.87-4.73 (br m, 1H), 4.42-4.29 (br m, 2H), 3.20 (s, 3H), 2.92-2.81 (br m, 2H), 2.75-
2.61 (br m, 2H), 2.20-2.01 (br m, 2H), 1.57 (s, 8H). FTIR: polypeptide bands at 3288, 1652, and 
1548 cm-1. 
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poly(2-(N-Boc-N-methylaminooxy)ethyl-L-homocysteine sulfoxide)70, Boc-mao-EhcO70. 
The oxidation of thioether groups was performed before removal of the N-Boc groups. To 
convert thioether groups to sulfoxides, a volume of 70 wt. % TBHP (32 eq per residue) was 
added to a solution of Boc-mao-Ehc70 in HFIP (20 mg/mL). The reaction was stirred at room 
temperature for 48 hours and then it was transferred to a 2000 MWCO dialysis bag and dialyzed 
against: (i) pyrogen free deionized milli-Q water (3.5L) containing sodium thiosulfate (1.2 g, 2.16 
mM) for 2 days to neutralize residual peroxide, (ii) pyrogen free milli-Q water (3.5 L) for 2 days 
to remove residual sodium thiosulfate. For each step above, dialysate was changed every 12 
hours. Within the first couple hours of dialysis, the polypeptide precipitated within the dialysis 
bag. The contents of the dialysis bag were removed and freeze dried to yield dense white solids 
with average yields of 90 to 95%, and complete conversion of thioether groups to sulfoxide 
groups. 1H NMR (400 MHz, TFA-d, 25 °C): δ 4.97-4.59 (br m, 3H), 3.53-3.28 (br m, 4H), 3.22 (s, 
3H), 2.69-2.47 (br m, 1H), 2.47-2.26 (br m, 1H), 1.56 (s, 8H). 
 
poly(2-(N-methylaminooxy)ethyl-L-homocysteine sulfoxide)70, mao-EhcO70. The removal 
of N-Boc groups was performed after oxidation of the thioether groups. To remove the N-Boc 
groups, Boc-mao-EhcO70 was dissolved in TFA (20 mg/mL) and allowed to stir at room 
temperature for 2 hours. The reaction mixture was then transferred to a 2000 MWCO dialysis 
bag and dialyzed against: (i) pyrogen free milli-Q water (3.5L) acidified to pH 2 with HCl for 2 
days to aid cobalt ion removal/counter ion exchange, and (ii) pyrogen free milli-Q water (3.5 L) 
for 2 days to remove residual HCl.  For each step above, dialysate was changed every 12 
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hours. The polypeptide solution remained clear throughout dialysis. The contents of the dialysis 
bag were removed and then freeze dried to yield the polypeptide as a white fluffy solid (95% 
yield) with > 99% removal of Boc groups. 1H NMR (400 MHz, D2O, 25 °C): δ 4.58-4.37 (br m, 
1H), 4.26-4.06 (br m, 2H), 3.28-2.95 (br m, 4H), 2.69 (s, 3H), 2.44-2.17 (br m, 2H). 
 
poly(2-(N-Boc-N-methylaminooxy)ethyl-L-homocysteine methyl sulfonium)70, Boc-mao-
EhcM70.  The alkylation of thioether groups was performed before removal of the N-Boc groups. 
To convert thioether groups in Boc-mao-Ehc70 to S-methyl sulfonium groups, iodomethane (5 eq 
per thioether group) was added to a 20 mg/mL suspension of Boc-mao-Ehc70 in 0.1 M 
phosphate buffer (pH 7). The reaction was covered with aluminum foil to protect iodomethane 
from light and the suspension was vigorously stirred for 48 hours at room temperature.  
Afterwards, the reaction mixture was transferred to a 2000 MWCO dialysis bag and dialyzed 
against: (i) pyrogen free deionized milli-Q water (3.5 L) containing NaCl (7 g, 35 mM) for 2 days 
to facilitate counterion exchange, (ii) pyrogen free milli-Q water (3.5 L) for 2 days to remove 
residual NaCl. For each step above, dialysate was changed every 12 hours. Within the first 
couple hours of dialysis, the polypeptide became soluble. The contents of the dialysis bag were 
removed and freeze dried to yield a dense white solid (93% yield), and complete conversion of 
thioether groups to S-methyl sulfonium groups. 1H NMR (400 MHz, D2O, 25 °C): δ 4.66-4.55 (br 
m, 1H), 4.49-4.30 (br m, 1H), 3.83-3.37 (br m, 3H), 3.25-3.15 (br m, 3H), 3.14-3.01 (br m, 3H), 
2.46-2.19 (br m, 2H), 1.61-1.38 (br m, 8H). 
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poly(2-(N-methylaminooxy)ethyl-L-homocysteine methyl sulfonium)70, mao-EhcM70 The 
removal of Boc-mao-EhcM70 was performed after alkylation of the thioether groups. To remove 
the N-Boc groups, Boc-mao-EhcM70 was dissolved in TFA (20 mg/mL) and allowed to stir at 
room temperature for 2 hours. The reaction mixture was then transferred to a 2000 MWCO 
dialysis bag and dialyzed against: (i) pyrogen free deionized milli-Q water (3.5 L) containing 
NaCl (7 g, 35 mM) for 2 days to facilitate counterion exchange, (ii) pyrogen free milli-Q water 
(3.5 L) for 2 days to remove residual NaCl. For each step above, dialysate was changed every 
12 hours. The polypeptide solution remained clear throughout dialysis. The contents of the 
dialysis bag were removed and then freeze dried to yield the polypeptide as a dense white solid 
(96% yield) with > 99% removal of Boc groups. 1H NMR (400 MHz, D2O, 25 °C): δ 4.68-4.52 (br 
m, 1H), 4.28-4.14 (br m, 2H), 3.83-3.37 (br m, 4H), 3.12-2.95 (br m, 3H), 2.73-2.61 (br m, 3H), 
2.50-2.23 (br m, 2H). 
 
poly(6-(2-N-Boc-N-methylaminooxy)ethylthio)-L-norleucine)70, Boc-mao-Etn70.  poly(L-
homoallylglycine)70, GHA70, (11 mg), and DMPA (5 mg, 0.02 mmol, 0.2 eq per residue) were 
placed in a 1 dram screw top vial.  THF was then added to give a 4 mg/mL resulting polymer 
concentration. 2-(N-Boc-N-methylaminooxy)ethyl mercaptan (82 mg, 0.39 mmol, 4 eq per 
residue) was then added via micropipette and the solution was degassed via sparging with N2 
for 10 minutes.  The vial was then sealed with parafilm and the solution was irradiated with UV 
light for 2.5 hours (Exo Terra Reptile Lamp) and let stir overnight.  The solution was then 
transferred to a 2000 MWCO dialysis bag and dialyzed against methanol for 24 hours with one 
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change of dialysate, followed by dialysis in water for 24 hours with one water change.  The 
solution was lyophilized to dryness to give the product as a white solid (31 mg, 95% yield).  1H 
NMR (400 MHz, TFA-d, 25 °C): δ 4.66 (br s, 1H), 4.44 (d, J = 5.4, 2H), 3.28 (s, 3H), 2.94 (t, J = 
5.1, 2H), 2.78-2.58 (br m, 2H), 2.24-1.27 (br m, 15H). 
 
poly(6-(2-N-Boc-N-methylaminooxy)ethylthio)-L-norleucine sulfoxide)70, Boc-mao-EtnO70. 
The oxidation of thioether groups was performed before removal of N-Boc groups.  Boc-mao-
EtnO70 (81 mg) was dissolved in HFIP (5.0 mL).  70% TBHP in water was then added (1.14 mL, 
8 mmol, 32 eq per residue).  The solution was let stir overnight and then dialyzed against water 
for 48 h with two water changes daily.  The resulting solution was lyophilized to dryness to give 
the product as a sticky, white solid (84 mg, 99% yield). 1H NMR (400 MHz, TFA-d, 25 °C): δ 
4.95-4.76 (br m, 2H), 4.67 (br s, 1H), 3.56-3.39 (br m, 2H), 3.35-3.16 (br m, 4H), 3.09 (br s, 1H), 
2.30-1.52 (br m, 15H). 
 
poly(6-(2-N-methylaminooxy)ethylthio)-L-norleucine sulfoxide)70, mao-EtnO70.  The removal 
of N-Boc groups was performed after oxidation of thioether groups. Boc-mao-EtnO70 (31 mg) 
was dissolved in TFA (2.0 mL).  The reaction was let stir for 3 hours at room temperature and 
then dialyzed against a pH 2 HCl solution (24 hr, 2 water changes), then against deionized 
water (24 hr, 2 water changes).  The resulting solution was lyophilized to dryness to give the 
product as a white solid (13 mg, 62% yield).  1H NMR (400 MHz, D2O, 25 °C): δ 4.40-3.97 (br m, 
3H), 3.30-2.84 (br m, 4H), 2.68 (s, 3H), 2.18-1.45 (br m, 6H). 
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General procedure for endcapping of polypeptides with PEG chains.  The general 
procedure for polymerization of Boc-mao-Ehc NCA was followed.  Once the reaction was 
determined to be complete by FTIR, a solution of α-methoxy-ω-isocyanoethyl-poly(ethylene 
glycol), PEG-NCO (MW = 1000 Da, 4 eq per Co(PMe3)4) in THF was added to the 
polymerization mixture inside a dinitrogen filled glovebox.  The reaction was let stand overnight, 
and then removed from the glovebox. 1-2 drops of 3M HCl were then added and the reaction 
was precipitated with water, centrifuged at 3000 rpm and the supernatant was discarded.  The 
pellet was washed 3 times with DI water to remove unconjugated PEG-NCO, and the resulting 
pellet was then lyophilized to yield PEG-endcapped polypeptide as a white solid.  To determine 
the molecular weight of the polypeptides (Mn), 1H NMR spectra were obtained in deuterated 
trifluoroacetic acid (TFA-d) or deuterated chloroform (CDCl3) containing 1-2 drops of TFA-d. 
Similar to procedures described in literature,48 the integral of the Boc-mao-Ehcn resonance at δ 
3.19 was compared to the integral of the polyethylene glycol resonance at δ 3.92 to obtain Boc-
mao-Ehcn lengths. 
3.5.4 Glycosylation of mao-EhcO70, mao-EhcM70, and mao-EtnO70 
Procedure A (saccharide-mao-EhcO70).  A sample of mao-EhcO70 was dissolved at 5 mg/mL in 
a 0.1 M buffer (acetate pH 4-6, phosphate pH 7) with or without 0.1 M aniline. Upon complete 
dissolution of mao-EhcO70, D-Glucose (5-500 eq) was added to the reaction mixture. The 
reaction was adjusted to the appropriate temperature (4-50 °C) and stirred for 1 to 4 days. The 
reaction mixture was then transferred to a 2000 MWCO dialysis bag and dialyzed against 
pyrogen free milli-Q water (3.5L) for 1 day to remove ions and excess saccharide. Dialysate 
changes were performed every 12 hours. The resulting solution was removed and freeze dried 
to yield a white fluffy solid with isolated yields ranging from 80 to 100%, and saccharide 
conjugation yields ranging from 15 to 95%. The degree of saccharide conjugation was 
quantified by comparing 1H NMR integrals of the N-methyl resonances of unconjugated 
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methylaminooxy groups (2.69 ppm) with the saccharide conjugated methylaminooxy groups 
(2.72-2.80 ppm).38 
Procedure B (glc-mao-EhcM70).  A sample of mao-EhcM70 was dissolved at 5 mg/mL in a 0.1 M 
buffer (acetate pH 4-6, phosphate pH 7) with or without 0.1 M aniline. Upon complete 
dissolution of mao-EhcM70, D-glucose (100 eq) was added to the reaction mixture. The reaction 
was adjusted to 25 °C and stirred for 4 days. The reaction mixture was then transferred to a 
2000 MWCO dialysis bag and dialyzed against (i) pyrogen free milli-Q water (3.5L) containing 
NaCl (7.0 g, 35mM) for 1 day to facilitate counterion exchange (ii) pyrogen free milli-Q water 
(3.5L) for 1 day to remove excess NaCl. Dialysate changes were performed every 12 hours. 
The resulting solution was removed and freeze dried to yield a white fluffy solid with isolated 
yields ranging from 91 to 99%, and saccharide conjugation yields ranging from 37 to 93%. The 
degree of saccharide conjugation was quantified by comparing 1H NMR integrals of the N-
methyl resonances of unconjugated methylaminooxy groups (2.69 ppm) with the saccharide 
conjugated methylaminooxy groups (2.82 ppm).38 
Procedure C (glc-mao-EtnO70).  A sample of mao-EtnO70 was dissolved at 1.5 mg/mL in 
a 0.1 M buffer (acetate pH 4-6, phosphate pH 7) with or without 0.1 M aniline to give a turbid 
solution. The D-glucose (50-500 eq) was then added to the reaction mixture. The reaction was 
stirred at 50 °C for 1 to 4 days. The reaction mixture was then transferred to a 2000 MWCO 
dialysis bag and dialyzed against pyrogen free milli-Q water (3.5L) for 1 day to remove ions and 
excess saccharide. Dialysate changes were performed every 12 hours. The resulting solution 
was removed and freeze dried to yield a white fluffy solid with isolated yields ranging from 70 to 
100%, and saccharide conjugation yields ranging from 60 to 100%. The degree of saccharide 
conjugation was quantified by comparing 1H NMR integrals of the N-methyl resonances of 
unconjugated methylaminooxy groups (2.69 ppm) with the saccharide conjugated 
methylaminooxy groups (2.80 ppm).38 
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glc-mao-EhcO70 (procedure A). 
1H NMR (400 MHz, D2O, 25 °C): δ 4.60-4.46 (br m, 5.9H), 4.28-4.09 (br m, 14.9H), 3.97-3.88 (br 
d, J = 12 Hz, 5.0H), 3.80-3.71 (br m, 4.9H), 3.61-3.47 (br m, 9.4H), 3.47-3.32 (br m, 9.4H), 3.31-
2.90 (br m, 13.8H), 2.81 (s, 13.8H), 2.69 (s, 1.0H, 2.39-2.14 (br m, 8.9H). 
 
Glc-mao-EhcM70 (procedure B).  
1H NMR (400 MHz, D2O, 25 °C): δ 4.67-4.52 (br m, 8H), 4.36-4.18 (br m, 20H), 4.00-3.88 (br m, 
7H), 3.85-3.31 (br m, 64H), 3.19-2.95 (br m, 21H), 2.92-2.73 (br m, 20H), 2.73-2.62 (br m, 1H), 
2.56-2.19 (br m, 13H). 
 
glc-mao-EtnO70 (procedure C). 
1H NMR (400 MHz, D2O, 25 °C): δ 4.38-4.07 (br m, 16H), 3.98-3.86 (br m, 3.9H), 3.81-3.68 (br 
m, 3.9H), 3.59-3.46 (br m, 7.4H), 3.45-3.30 (br m, 8.2H), 3.28-3.13 (br m, 3.8H), 3.14-3.02 (br 
m, 4.2H), 3.02-2.85 (br m, 8.3H), 2.84-2.72 (br m, 13H), 2.70-2.65 (br m, 1H), 2.06-1.71 (br m, 
16.4H), 1.72-1.43 (br m, 11.8H). 
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3.5.5 Stability of neoglycoconjugates 
Samples of glc-mao-EhcO70, glc-mao-EhcM70, and glc-mao-EtnO70 (each having > 90% 
saccharide functionalization) were dissolved in a 0.2 M phosphate buffer (1.0 mg/mL) at either 
pH 5.5 or 7.4. These solutions were then transferred to 2000 MWCO dialysis bags and dialyzed 
at 37 °C against 200 mL of a 0.2 M phosphate buffer at either pH 5.5 or 7.4. Samples were 
dialyzed for 1 week with dialysate changes every day. After 1 week the contents of the dialysis 
bags were collected and lyophilized. 1H NMR spectra of the resulting solids were obtained and 
the integrals of N-methyl group resonances at 2.80 and 2.69 ppm were compared to determine 
the relative amounts of glucose neoglycoconjugate residues and free methylaminooxy residues, 
respectively.38 This data was used to calculate the percentage of glucose released from the 
polypeptide neoglycoconjugates after 1 week. Error bars are consistent with the standard 
deviation for n = 3. 
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Chapter 4: Synthesis and Applications of poly(5,6-epoxy-L-
norleucine) 
4.1 Abstract 
An epoxide-bearing α-helical polypeptide, poly(5,6-epoxy-L-norleucine), Enl as 
synthesized via post-polymerization mCPBA oxidation of poly(L-homoallylglycine).  Enl was 
found to be soluble in polar organic solvents and allowed high yield conjugation reactions with a 
variety of functional thiols under basic conditions.  Thiol conjugates of Enl displayed high 
aqueous solubility and partially disordered conformations due to the presence of hydroxyl 
groups close to the polypeptide backbone.  Enl conjugates with diethylene glycol derived thiols 
showed LCST properties in water, which could be modulated by varying concentration, varying 
polypeptide composition, and through oxidation of polypeptide thioether groups. 
4.2 Introduction 
 Functional polypeptides have been shown to be useful for a variety of biomedical 
applications.1  However, the development of polypeptides with complex biomimetic functionality 
is a continuing challenge.  Post-polymerization modification of polypeptides has emerged as an 
advantageous method of introducing functionality, because it avoids the tedious synthetic 
procedures often associated with functional monomers and allows for the synthesis of a diverse 
array of functional polypeptides from a single monomeric precursor.2, 3  Residues in 
polypeptides containing an alkene functionality have been utilized for post-polymerization 
modification via thiol-ene chemistry and alkene oxidation chemistry.2, 4, 5  Recently, Deming and 
coworkers reported the synthesis of poly(L-homoallylglycine) (GHA), an alkene-bearing α-helical 
polypeptide that could be modified efficiently under mild conditions using thiol-ene chemistry.6  
However, the resulting thioethers often lacked aqueous solubility due to long hydrophobic side 
chains (Figure 4.1), and the chemistry performed best in organic solvent systems, which limited 
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the polarity of usable thiols.6, 7  Therefore, a method of synthesizing functional polypeptides with 
higher aqueous solubility was desired.  The presence of hydroxyl groups on polypeptide 
sidechains is known to increase the aqueous solubility of polypeptides.8 For this reason, an 
epoxide functional polypeptide approach for the synthesis of water soluble GHA derived 
thioethers was envisioned (Figure 4.2). 
 
Figure 4.1 Structural variants of functional polypeptides containing thioether side-chain groups.  
A) Poly(S-alkyl-L-homocysteine), R-CH, synthesized via epoxide alkylation and demethylation of 
poly(L-methionine).  B) Thiol modified poly(5,6-epoxy-L-norleucine), R-Enl, via nucleophilic ring-
opening. C) Thiol modified poly(L-homoallylglycine), R-GHA, via thiol-ene conjugation. 
Polypeptides containing epoxide functionality were reported by Daly and coworkers, but 
no subsequent modification was attempted.9  However, previous studies involving the ring 
opening of epoxide bearing polymers with thiols under basic conditions have shown the 
chemistry to be regioselective, and highly efficient under mild conditions.10-12  Therefore, this 
methodology could be readily applied for the synthesis of thioether containing polypeptides with 
functional side chains. 
 
Figure 4.2 Oxidation of poly(L-homoallylglycine), GHA, to give poly(5,6-epoxy-L-norleucine), Enl, 
for synthesis of thiol functionalized polypeptides, R-Enl.  
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The Deming lab previously synthesized epoxide derived thioether containing 
polypeptides by reacting poly(L-methionine) (M) residues with oligoethylene glycol (OEG) 
epoxides to generate sulfonium salts then using sulfonium dealkylation chemistry to generate 
functional thioether containing polypeptides.  The resulting polypeptides were water-soluble with 
thermoresponsive solution properties.8, 13  Enl derived thioether containing polypeptides have 
long hydrophobic side chains, but their solubilizing hydroxyl groups are closer to their 
backbones (Figure 4.1).  We predicted that this structural difference may lead to differences in 
conformation, solubility, and thermoresponsive properties compared to M derived β-hydroxy 
thioethers.  
We predicted that ring opening of an epoxide-bearing polypeptide would proceed readily 
with thiols of varied polarity and functionality under mild conditions.  We also hypothesized that 
OEG derived thiols could be utilized to give polypeptides with thermoresponsive properties 
similar to what has been reported in other OEG functionalized polypeptide systems.14-16  
Therefore, poly(5,6-epoxy-L-norleucine) (Enl) was synthesized and subsequently reacted with a 
variety of thiols under basic conditions.  The solubility, conformational features, and 
thermoresponsive properties of the resulting conjugates were investigated. 
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4.3 Results and Discussion 
 
Figure 4.3 1H NMR Spectrum of Enl55 (400 MHz, DMSO-d6, 25 °C).  95% consumption of 
alkene groups based on integration of alkene resonances. 
 
Figure 4.4 Normalized ATR-FTIR absorption (1800-500 cm-1) of GHA55 (red) and Enl55 (blue).  
Enl55 band at 835 cm-1 is consistent with an epoxide ring deformation. 
 Enl55 was synthesized via post-polymerization mCPBA oxidation of GHA55.9  Near 
complete disappearance of alkene resonances was observed via 1H NMR (Figure 4.3). 
The formation of the epoxide functional groups was confirmed using ATR-FTIR and 13C CP-MAS 
NMR (Figure 4.4, 4.5).17, 18  The normalized ATR absorbances of GHA55 and Enl55 were 
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compared (Figure 4.4).  The FTIR spectra of Enl55 contained an absorbance at 835 cm-1, which 
is in a known stretching frequency range for epoxide ring deformation.18, 19  GPC analysis of 
Enl55 showed uniform chain length distribution with low dispersity (Figure 4.6). 
 
Figure 4.5 13C CP-MAS NMR spectra overlay of A) GHA55 B) Enl55 and C) GL-Enl55.  Asterisks 
indicate spinning sidebands. 
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Figure 4.6 GPC Chromatogram of Enl55 in 0.5% (w/w) KTFA in HFIP at 10 mg/mL. RIU = 
arbitrary refractive index units, Mw/Mn= 1.26. 
 
Figure 4.7 Circular dichroism spectrum of Enl55 in HFIP at 0.1 mg/mL, 20 °C. 
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Figure 4.8 Base-catalyzed thiol-epoxy chemistry of Enl55.  Yield is total isolated yield of fully 
functionalized polypeptide. * = H2O/room temp, 10 eq thiol. 
 After confirming the oxidation of alkene to epoxide, the conformation of Enl55 was 
studied via CD spectroscopy (Figure 4.7).  Enl55 displayed a predominately α-helical 
conformation, which demonstrated that chirality of the polypeptide backbone was maintained 
during the course of the oxidation.20  The reactivity of Enl55 was then examined by treating the 
polypeptide with a variety of thiols under basic conditions (Figure 4.8).  OEG derived thiols were 
chosen for initial Enl55 conjugation studies, due to their solubilizing properties, ease of 
synthesis, and the known thermoresponsive properties of OEG containing polypeptides.6, 8, 13  
Reactions with thiols derived from ethylene glycols of varying oligomer lengths proceeded with 
high functionalization under mild conditions.  Successful thiol conjugation was confirmed via 1H 
NMR, ATR-FTIR, and 13C CP-MAS NMR (Figure 4.5, 4.9).  2-methoxyethane-1-thiol modified 
poly(5,6-epoxy-L-norleucine)55 (mEG1-Enl55) was chosen for ATR-FTIR analysis due to its 
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structural simplicity (Figure 4.9).  The disappearance of the epoxy C-O band at 835 cm-1 
demonstrated that ring opening of Enl55 under basic conditions went to completion.17, 18  GPC 
analysis of mEG4-Enl55 showed a significant increase in molecular weight, while the polypeptide 
maintained the uniform weight distribution and low dispersity of its Enl55 precursor (Figure 4.10). 
 
Figure 4.9 Normalized ATR-FTIR absorption (1800-500 cm-1) of Enl55 (blue) and mEG1-Enl55 
(red).  Note the disappearance of epoxide ring deformation band at 835 cm-1 after the thiol-
epoxy reaction. 
 
Figure 4.10 GPC Chromatograms of Enl55 (blue, Mw/Mn= 1.26) and mEG4-Enl55 (red, Mw/Mn= 
1.27) in HFIP containing 0.5 % (w/w) KTFA at 10 mg/mL. 
 
18001600140012001000 800 600
0.0
0.2
0.4
0.6
0.8
1.0
N
o
rm
a
li
z
e
d
 A
b
s
o
rb
a
n
c
e
Wavenumber (cm
-1
)
 Enl
55
 mEG
1
-Enl
55
0 5 10 15 20 25 30
0
4
8
12
16
d
R
I 
x
 1
0
6
 (
R
IU
)
Time (min)
 Enl
55
 mEG
4
-Enl
55
101 
 
As expected, thiol-epoxy ring-opening products of Enl showed considerably higher 
aqueous solubility than thiol-ene modified GHA polypeptides.  GHA was water insoluble when 
modified with 2-[2-(2-methoxyethoxy)ethoxy]ethanethiol (mEG3SH).6  However, the ring-opening 
conjugate of Enl demonstrated good aqueous solubility (> 10 mg/mL) when modified with the 
same thiol.  This notable increase in solubility was likely due to the addition of side chain 
hydroxyl groups in Enl, which are not present in the GHA thiol-ene conjugate (Figure 4.1).8 
  
Figure 4.11 Circular dichroism spectra of mEG2-Enl55 (black, 50% α-helix), mEG3-Enl55 (red, 
63% α-helix), mEG4-Enl55 (blue, 57% α-helix), and EG4-Enl55 (green, 48% α-helix) polypeptides 
in DI water at 0.1 mg/mL, 20 °C.  
The conformational properties of water soluble Enl OEG conjugates (EGn-Enl) were 
analyzed using circular dichroism spectroscopy (Figure 4.11).  EGn-Enl polypeptides displayed 
partially disordered conformations in aqueous solution, which was assumed to be due to 
hydration of their side chain hydroxyl groups.  
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Figure 4.12 Circular dichroism spectra of mEG2-Enl55 at 20 °C in DI water (black, 50% α-helix) 
and methanol (red, 72% α-helix). 
In order to check the effects of water hydration, the circular dichroism spectrum of 
mEG2-Enl55 was collected in methanol and compared to its spectrum in water (Figure 4.12).  
The increased α-helical content in methanol confirmed the effect of aqueous solvation on Enl 
derivatives.  EGn-E polypeptides were found to be significantly more disordered than related, 
previously synthesized GHA and M derived functional polypeptides (Figure 4.13).6, 8 
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Figure 4.13 Conformational Comparison of Enl derivatives to previously reported OEG 
thioether containing polypeptides.  Circular Dichroism spectra were collected in DI water at 20 
°C.  A)  mEG2-Enl (black, 0.1 mg/mL, 50% α-helix), B) mEG1-CH (red, 0.5 mg/mL, 84% α-helix), 
C) mEG4-Enl (green, 0.1 mg/mL 57% α-helix), D) mEG4-GHA (blue, 0.5 mg/mL 71% α-helix). 
After characterizing EGn-Enl polypeptides, the reactivity of Enl55 with more polar thiols 
was examined.  Thioglycerol was utilized due to its commercial availability and water solubilizing 
effect by addition of hydrogen bond donors to the polypeptide.  Thioglycerol functionalized Enl55 
(GL-Enl55) was found to have high aqueous solubility for a nonionic polypeptide, readily 
dissolving to give solutions up to 90 mg/mL in water.  Enl could also be readily functionalized 
with thiols in aqueous media, as demonstrated by its reaction with water soluble N,N-dimethyl-
200 210 220 230 240 250
-40
-20
0
20
40
60
80
[
] 
x
 1
0
-3
Wavelength (nm)
 A
 B
200 210 220 230 240 250
-40
-20
0
20
40
60
80
[
] 
x
 1
0
-3
Wavelength (nm)
 C
 D
104 
 
cysteamine-carboxybetaine (CB-SH).  However, CB-Enl55 was found to possess poor aqueous 
solubility near neutral pH, likely due to cooperative ion pairing, which is known to occur with 
betaine-containing zwitterionic polymers.21, 22  However, this polypeptide is soluble under acidic 
conditions where the carboxylate is neutralized, displaying a disordered conformation at pH 2 in 
water (Figure 4.14). 
 
Figure 4.14 Circular Dichroism spectrum of CB-Enl55 at pH 2. Polypeptide was dissolved at 0.1 
mg/mL in an aqueous buffer containing 100 mM phosphate and 10 mM Tris, and the pH was 
adjusted using 0.1 M HCl. 
After demonstrating the versatility of thiol addition to Enl, we sought to investigate 
whether EGn-Enl55 polypeptides had similar thermoresponsive properties as previously reported 
oligoethylene glycol functionalized polypeptides.13, 15  Out of the 6 oligoethylene glycol 
conjugates of Enl that were prepared, only mEG2-Enl55 and etEG2-Enl55 demonstrated 
thermoresponsive behavior in water.  mEG1-Enl55 was found to be insoluble in water at all 
temperatures studied, due to its mostly hydrophobic side chain, while mEG3-Enl55, mEG4-Enl55, 
and EG4-Enl55 were soluble at all temperatures studied. The thermoresponsive properties of Enl 
conjugates were highly sensitive to oligoethylene glycol length, with longer oligoethylene glycol 
groups giving fully water soluble polypeptides assisted by the proximity of their hydroxyl groups 
to their polypeptide backbones (Figure 4.1). 
200 210 220 230 240 250
-10
-5
0
5
10
[
] 
x
 1
0
-3
Wavelength (nm)
105 
 
 The thermoresponsive behavior of EG2-Enl conjugates were studied in greater detail.  
etEG2-Enl55 solutions possessed a cloud point below room temperature and were not analyzed 
further.  The cloud point of mEG2-Enl55 solutions was measured via UV-Vis spectroscopy at 
different concentrations (Figure 4.15). 
 
Figure 4.15 Concentration dependence of mEG2-Enl55 heating curve in water.  1% w/w solution 
in DI water (black) shows a sharp transition with a cloud point temperature of 40 °C, while 0.2% 
w/w solution in DI water (red) has a broader transition and higher cloud point temperature (53 
°C). 
 Increasing polypeptide concentration facilitated intermolecular aggregation, which led to  
a sharper phase transition that occurred at a significantly lower temperature.14, 23  However, 
even at 1% w/w, the cloud point temperature of mEG2-Enl55 was beyond the physiological 
temperature range.  Therefore, we sought to further modulate the cloud point temperature of 
mEG2-Enl55 through the incorporation of less soluble etEG2-Enl residues (Figure 4.16).  A 1:1 
statistical copolypeptide of mEG2-Enl and etEG2-Enl was synthesized by reacting Enl55 with a 
1:1 ratio of 2-(2-methoxyethoxy)ethane-1-thiol (mEG2SH) and 2-(2-ethoxyethoxy)ethane-1-thiol 
(etEG2SH) under basic conditions.  
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Figure 4.16 Modulation of mEG2-Enl55 cloud point temperature at 0.2 % w/w through 
incorporation of etEG2-Enl residues (x = etEG2-Enl, y = mEG2-Enl).  mEG2-Enl55 (red, x = 0, y = 
1) exhibits a cloud point temperature of 53 °C.  However, a 1:1 statistical copolymer of etEG2-
Enl and mEG2-Enl (blue, x = 0.5, y = 0.5) exhibits a physiologically relevant cloud point 
temperature (34 °C). 
The increased helicity and lower solubility of previously synthesized oligoethylene glycol-
homocysteine (OEG-CH) derivatives allowed for higher tunability of cloud point temperature, 
while the closer proximity of hydroxyl groups to the backbones of Enl derived thioethers led to 
higher solubility and therefore less adjustment of cloud point temperature (Figure 4.1).13  
Though the high solubility of Enl conjugates made tuning their cloud points difficult, the 
incorporation of etEG2-Enl residues into mEG2-Enl polypeptides allowed enough tunability to 
provide a physiologically relevant cloud point temperature (34 °C). 
 Previously, OEG-CH polypeptides demonstrated a loss of ordered secondary structure 
and loss of thermoresponsive properties upon oxidation of their thioethers to sulfoxides.13  We 
predicted that mEG2-Enl55 and etEG2-Enl55 would respond similarly to oxidation, therefore we 
oxidized these polypeptides to their corresponding sulfoxides, mEG2-EnlO55 and etEG2-EnlO55 
(Figure 4.17). 
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Figure 4.17 Oxidation of mEG2-Enl55 and etEG2-Enl55.  etEG2-Enl55 required longer reaction 
time due to increased hydrophobicity. 
mEG2-EnlO55 and etEG2-EnlO55 exhibited partially disordered conformations, but not as 
disordered as previously synthesized OEG-CHO polypeptides (Figure 4.18, 4.19).24  Both 
polymers displayed good aqueous solubility and neither polymer showed thermoresponsive 
behavior in water after oxidation.  Therefore, oxidation of Enl derived thioether residues to their 
corresponding sulfoxides was an effective method of switching off LCST properties, similar to 
OEG-CH polypeptides.13  Since sulfoxides can be readily reduced back to thioethers, reversible 
switching of thermoresponsive behavior in water may be possible.25, 26 
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Figure 4.18 A) Comparison of circular dichroism spectra for mEG2-Enl55 (red, 50% α-helix) and 
mEG2-EnlO55 (black, 23% α-helix) showing change in chain conformation after oxidation.  Circular 
dichroism spectra collected at 0.1 mg/mL in DI water at 20 °C.  B) Comparison of circular 
dichroism spectra for mEG2-EnlO55 (black, 0.1 mg/mL, 23% α-helix) and mEG1-CHO60 (red, 0.25 
mg/mL, 5% α-helix). 
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Figure 4.19 Circular dichroism spectrum of etEG2-EnlO55 in DI water at 0.1 mg/mL, 20 °C (32% 
α-helix). 
4.4 Conclusion 
A new epoxide functionalized polypeptide was synthesized and then modified by 
reaction with thiols to furnish polypeptides with a variety of functional groups tethered with 
thioether linkages.  These R-Enl polypeptides displayed higher aqueous solubility and more 
disordered chain conformations compared to structurally related, previously reported 
polypeptides, due to the proximity of water solubilizing side-chain hydroxyl groups to the 
polypeptide backbones.  Thiol conjugation to Enl was found to be an effective method of 
synthesizing a variety of water-soluble non-ionic polypeptides.  Though the high water solubility 
of Enl derivatives made the design of thermoresponsive polypeptides challenging, EG2-Enl 
polypeptides demonstrated thermoresponsive behavior that was modified by altering sample 
concentration and polypeptide composition, and could be switched off by oxidizing the thioether 
side-chains.  The versatility and high water solubility of Enl derivatives gives them potential for a 
variety of biomaterial applications. 
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4.5 Experimental 
4.5.1 Materials and Methods 
Unless specified, all post-polymerization modification chemistry was performed in glass 
vials under ambient atmosphere.  Thiol-epoxy reactions were performed in 1 dram screw top 
glass vials capped with septa to allow sparging.  Small molecule chemistry was performed in 
heat-dried glassware under a nitrogen atmosphere, unless otherwise specified. THF and 
hexanes were degassed with dinitrogen and passed through an alumina column before use. All 
other reagents and solvents were used as received.  Poly(L-homoallylglycine)55, OEG-thiols 
(except 2-(2-methoxyethoxy)ethane-1-thiol and 2-(2-ethoxyethoxy)ethane-1-thiol), and N,N-
dimethyl-cysteamine-carboxybetaine (CB-SH) have been previously reported and synthesized 
by known procedures.6, 27  Unless otherwise specified, all reactions were performed at ambient 
temperature (ca. 20 °C).  In-house deionized water was used for all aqueous chemistry and 
dialysis unless otherwise specified.  Circular dichroism (CD) spectroscopy was performed on 
samples prepared using deionized water filtered through a Millipore Milli-Q Biocel A10 filter 
system unless otherwise specified. CD spectra were collected using 0.1 mg /mL solutions of 
polypeptide on either an Olis DSM 10 spectrophotometer or a JASCO J-715 spectrophotometer 
using a 0.1 cm path length quartz cuvette.  Percent α-helical content of polypeptides was 
estimated using the formula % α-helix = 100 × (−[θ]222 + 3000)/39000), where [θ]222 is the 
measured molar ellipticity at 222 nm.28  Thin-layer chromatography was performed with EMD 
gel 60 F254 plates (0.25 mm thickness) and spots were visualized using a UV lamp or KMnO4 
stain.  Silicycle Siliaflash G60 silica (60-200 µm) was used for all column chromatography.  
Silica used for chromatographic purification of NCA monomers was dried under vacuum at 250 
°C for 48 hours and then stored in a dinitrogen filled glovebox.  Compositions of mobile phases 
used for chromatography and compositions of solvent systems used for circular dichroism are 
given in volume percents.  Dialysis was performed with regenerated cellulose tubing obtained 
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from Spectrum labs.  NMR spectra of solution samples were recorded on a Bruker AV400 
instrument with chemical shifts reported relative to the deuterated solvent used.  Solid state 13C 
Cross Polarization-Magic Angle Spinning NMR was conducted on a Bruker AV III HD instrument 
with a magnetic field of 14.1 T.  10 mg of GHA55, 10 mg of Enl55, and 50 mg of GL-Enl55 were 
used for acquisition of spectra. The contact time was 1.5 ms with a recycle delay of 5 s.  The 
sample spinning rate was 10 kHz.  Solid state FTIR spectra were collected using a Thermo 
Scientific Nicolet iS5 FT-IR spectrophotometer with an ID7 ATR Sampling Accessory.  Cloud 
point temperature measurements were recorded on an HP 8453 spectrophotometer equipped 
with an Agilent 8909A temperature controller. Tandem gel permeation chromatography/light 
scattering (GPC/LS) was performed at 25 oC using an SSI Accuflow Series III pump equipped 
with Wyatt DAWN EOS light scattering and Optilab REX refractive index detectors. Separations 
were achieved using 100 Å and 1000 Å PSS-PFG 7 μm columns at 30 ºC with 0.5% (w/w) 
KTFA in 1,1,1,3,3,3-hexafluoroisopropanol (HFIP) as eluent and sample concentrations of 10 
mg/ml. 
4.5.2 Thiol Synthesis 
 
2-methoxyethyl 4-methylbenzenesulfonate.  This compound was synthesized using a 
procedure for a related molecule.6  H2O (7.00 mL) was added to 2-methoxyethanol (2.26 g, 29.7 
mmol) and NaOH (2.37 g, 59.4 mmol).  Tosyl chloride (5.95 g, 31.2 mmol) was dissolved in THF 
(7.00 mL) and added dropwise over ice with stirring.  The reaction was let warm to ambient 
temperature overnight.  Diethyl ether (14.0 mL) was then added to the reaction and the mixture 
was taken up into a separatory funnel and partitioned.  The aqueous layer was washed with 
diethyl ether (3 x 3.50 mL) then the combined organic fractions were washed with H2O (3 x 14.0 
mL).  The organic layer was dried with anhydrous sodium sulfate, decanted and evaporated to 
dryness to give the product as a clear oil (4.64 g, 69% yield).  1H NMR (400 MHz, CDCl3, 25 
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°C): δ 7.80 (d, J = 8.3 Hz, 2H), 7.34 (d, J = 8.0, 2H), 4.18-4.13 (m, 2H), 3.60-3.54 (m, 2H), 3.30 
(s, 3H), 2.44 (s, 3H). 
 
S-(2-methoxyethyl) ethanethioate.  This compound was synthesized using a procedure for a 
related molecule.6  2-methoxyethyl 4-methylbenzenesulfonate (2.04 g, 8.86 mmol) and 
potassium thioacetate (1.26 g, 11.1 mmol) were dissolved in a round bottom flask containing 
acetone (54.0 mL).  A reflux condenser was added and the reaction was stirred vigorously 
overnight at 50 °C.  Solvent was removed via vacuum and the resulting mixture was dissolved in 
a biphasic mixture of 16.0 mL DCM and 16.0 mL H2O, taken up into a separatory funnel, and 
partitioned.  The aqueous layer was washed with 2x 16.0 mL DCM and combined organics were 
washed with 6.0 mL brine.  The organic layer was dried with anhydrous sodium sulfate, 
decanted, and evaporated to dryness to give the product as a yellow oil (0.370 g, 31% yield).  
1H NMR (400 MHz, CDCl3, 25 °C): δ 3.51 (t, J = 6.3 Hz, 2H), 3.36 (s, 3H), 3.09 (t, J = 6.2 Hz, 
2H), 2.34 (s, 3H). 
 
2-methoxyethane-1-thiol.  Adapted from a procedure for deprotection of a related molecule.29 
Methanol (7.50 mL) and conc. HCl (0.600 mL) were added to a sealed pressure tube containing 
S-(2-methoxyethyl) ethanethioate (0.320 g, 2.38 mmol).  The reaction mixture was stirred at 100 
°C for 3 hours.  The reaction was let cool to ambient temperature and then H2O (7.50 mL) was 
added.  This mixture was extracted with 3x 6.00 mL DCM.  Combined organic extracts were 
then washed with 3x 6.00 mL H2O and 1x 6.00 mL brine, dried with anhydrous sodium sulfate, 
decanted, and rotovapped (30 °C, 400 mbar) to give the product as a yellow oil (0.200 g, 95% 
yield).  Spectral data agreed with previously published results.30 
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2-(2-methoxyethoxy)ethyl 4-methylbenzenesulfonate.  The procedure for the synthesis of 2-
methoxyethyl 4-methylbenzenesulfonate was followed.  Diethylene glycol monomethyl ether 
(5.1 g) was used to prepare the product, obtained as a clear oil (9.00 g, 77% yield).  1H NMR 
(400 MHz, CDCl3, 25 °C): δ 7.81-7.75 (m, 2H), 7.33 (dd, J = 8.6 Hz, 0.60 Hz), 4.20-4.11 (m, 
2H), 3.71-3.43 (br m, 6H), 3.33 (s, 3H), 2.43 (s, 3H). 
 
S-(2-(2-methoxyethoxy)ethyl) ethanethioate.  The procedure for the synthesis of S-(2-
methoxyethyl) ethanethioate was followed.  2-(2-methoxyethoxy)ethyl 4-
methylbenzenesulfonate (8.97 g) was used to prepare the product, obtained as a yellow oil 
(5.50 g, 94% yield).  1H NMR (400 MHz, CDCl3, 25 °C): δ 3.65-3.49 (br m, 6H), 3.34 (s, 3H), 
3.10 (t, J = 6.5 Hz, 2H), 2.33 (s, 3H). 
 
2-(2-methoxyethoxy)ethane-1-thiol.  This compound was synthesized using a procedure for a 
related molecule.6 Methanol (20.0 mL) and conc. HCl (1.50 mL) were added to a sealed 
pressure tube containing S-(2-(2-methoxyethoxy)ethyl) ethanethioate (2.02 g, 11.3 mmol).  The 
reaction mixture was stirred at 100 °C for 3 hours.  The reaction was let cool to ambient 
temperature and then H2O (20.0 mL) was added.  This mixture was extracted with 3x 15.0 mL 
DCM.  Combined organic extracts were then washed with 3x 15.0 mL H2O and 1x 15 mL brine, 
dried with anhydrous sodium sulfate, decanted, and evaporated to dryness to give the product 
as a yellow oil (1.18 g, 77% yield). Spectral data agreed with previously published results.31 
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2-(2-ethoxyethoxy)ethyl 4-methylbenzenesulfonate.  The procedure for the synthesis of 2-
methoxyethyl 4-methylbenzenesulfonate was followed.  Diethylene glycol monoethyl ether (2.02 
g) was used to prepare the product, obtained as a clear oil (3.57 g, 82% yield).  1H NMR (400 
MHz, CDCl3, 25 °C): δ 7.82-7.76 (m, 2H), 7.33 (d, J = 8.0 Hz, 2H), 4.19-4.14 (m, 2H), 3.71-3.66 
(m, 2H), 3.60-3.55 (m, 2H), 3.53-3.45 (m, 4H), 2.44 (s, 3H), 1.19 (t, J = 7.0 Hz, 3H). 
 
S-(2-(2-ethoxyethoxy)ethyl) ethanethioate.  The procedure for the synthesis of S-(2-
methoxyethyl) ethanethioate was followed.  2-(2-ethoxyethoxy)ethyl 4-methylbenzenesulfonate 
(2.25 g) was used to prepare the product, obtained as a yellow oil (1.26 g, 84% yield).  1H NMR 
(400 MHz, CDCl3, 25 °C): δ 3.66-3.45 (br m, 8H), 3.10 (t, J = 6.5 Hz, 2H), 2.33 (s, 3H), 1.21 (t, J 
= 7.0 Hz, 3H) 
 
2-(2-ethoxyethoxy)ethane-1-thiol.  The procedure for the synthesis of 2-(2-
methoxyethoxy)ethane-1-thiol was followed.  S-(2-(2-ethoxyethoxy)ethyl) ethanethioate (1.25 g) 
was used to prepare the product, obtained as a clear oil (0.740 g, 76% yield). 1H NMR (400 
MHz, CDCl3, 25 °C): δ 3.63-3.46 (br m, 8H), 2.67 (dt, J = 8.2 Hz, 6.5 Hz, 2H), 1.56 (t, J = 8.2 
Hz, 1H), 1.18 (t, J = 7.0 Hz, 3H).  13C NMR (100 MHz, CDCl3, 25 °C): δ 72.9, 70.3, 69.7, 66.6, 
24.2, 15.1. 
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4.5.3 Post-polymerization Chemistry 
 
poly(5,6-epoxy-L-norleucine)55, Enl55. GHA55 (45.2 mg) was dissolved in DCM (5 mg/mL). m-
CPBA was added to the solution (210.0 mg, 2.5 eq).  The reaction was let stir for 2 days then 
transferred to a 2000 MWCO dialysis bag.  The reaction mixture was dialyzed against methanol 
for 1 day, then DI water for 1 day, with 2 dialysate changes daily.  The dialyzed polymer was 
lyophilized to dryness, yielding a white solid (41.5 mg, 81% yield).  1H NMR (400 MHz, DMSO-
d6, 25 °C): δ 8.68-7.50 (br m, 1H), 4.36-3.85 (br m, 1H), 3.03-2.78 (br m, 1H), 2.70-2.56 (br m, 
1H), 2.42-2.28 (br m, 1H), 2.20-1.26 (br m, 4H) 13C NMR (CP-MAS, 25 °C): δ 175.8, 57.3, 50.9, 
46.2, 26.9.   
General Procedure for base-catalyzed thiol-epoxy ring opening of Enl.  Enl was dissolved 
in DMF to give a 3 mg/mL solution in a 1 dram screw top vial.  5 equivalents of thiol per residue 
were added and the solution was degassed for 10 minutes.  6 equivalents of DBU (50mg/mL in 
DMF, degassed) were added to the reaction mixture via syringe and the reaction was let stir 
under nitrogen at 40 °C for 2 days.  The reaction mixture was dialyzed against DI water (2000 
MWCO) for 2 days with 2 water changes daily.  The dialyzed polymer was lyophilized to 
dryness, yielding a white solid. 
 
mEG1-Enl55.  The general procedure for base-catalyzed thiol-epoxy ring opening of Enl was 
followed.  Enl55 (5.0 mg) and 2-methoxyethane-1-thiol (5 eq per Enl residue) were used to 
116 
 
prepare the product, obtained as a white solid (8.5 mg, 100% yield).  1H NMR (400 MHz, d-TFA, 
25 °C): δ 5.04-4.38 (br m, 1H), 4.20-3.98 (br m, 1H), 3.91 (br t, J = 5.9 Hz, 2H), 3.68-3.51 (br m, 
3H), 3.15-2.60 (br m, 4H), 2.32-1.76 (br m, 4H). 
 
mEG2-Enl55.  The general procedure for base-catalyzed thiol-epoxy ring opening of Enl was 
followed.  Enl55 (2.5 mg) and 2-(2-methoxyethoxy)ethane-1-thiol (5 eq per Enl residue) were 
used to prepare the product, obtained as a white solid (5.0 mg, 98% yield).  1H NMR (400 MHz, 
D2O, 25 °C): δ 4.27-3.87 (br m, 1H), 3.79-3.43 (br m, 7H), 3.27 (s, 3H), 2.80-2.44 (br m, 4H), 
2.15-1.26 (br m, 4H) 
 
etEG2-Enl55.  The general procedure for base-catalyzed thiol-epoxy ring opening of Enl was 
followed.  Enl55 (6.3 mg) and 2-(2-ethoxyethoxy)ethane-1-thiol (5 eq per Enl residue) were used 
to prepare the product, obtained as a white solid (9.9 mg, 73% yield).  1H NMR (400 MHz, d-
TFA, 25 °C): δ 5.10-4.46 (br m, 1H), 4.21-3.69 (br m, 9H), 3.37-2.58 (br m, 4H), 2.43-1.76 (br m, 
4H), 1.41 (t, J = 7.1, 3H). 
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mEG3-Enl55.  The general procedure for base-catalyzed thiol-epoxy ring opening of Enl was 
followed.  Enl55 (2.6 mg) and 2-[2-(2-methoxyethoxy)ethoxy]ethanethiol (5 eq per Enl residue) 
were used to prepare the product, obtained as a white solid (5.1 mg, 82% yield).  1H NMR (400 
MHz, D2O, 25 °C): δ 4.32-3.87 (br m, 1H), 3.79-3.31 (br m, 11H), 3.30-3.20 (br s, 3H), 2.82-2.40 
(br m, 4H), 2.12-1.33 (br m, 4H). 
 
mEG4-Enl55.  The general procedure for base-catalyzed thiol-epoxy ring opening of Enl was 
followed.  Enl55 (2.0 mg) and 2-[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]ethanethiol (5 eq per Enl 
residue) were used to prepare the product, obtained as a white solid (5.5 mg, 100% yield).  1H 
NMR (400 MHz, D2O, 25 °C): δ 4.27-3.88 (br m, 1H), 3.79-3.47 (br m, 15H), 3.27 (s, 3H), 2.81-
2.45 (br m, 4H), 2.11-1.32 (br m, 4H). 
 
EG4-Enl55.  The general procedure for base-catalyzed thiol-epoxy ring opening of Enl was 
followed.  Enl55 (2.0 mg) and 1-mercapto-11-hydroxy-3,6,9-trioxaundecane (5 eq per Enl 
residue) were used to prepare the product, obtained as a white solid (4.6 mg, 88% yield).  1H 
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NMR (400 MHz, D2O, 25 °C): δ 4.38-3.82 (br m, 1H), 3.81-3.17 (br m, 15H), 2.94-2.26 (br m, 
4H), 2.07-1.30 (br m, 4H). 
 
GL-Enl55.  The general procedure for base-catalyzed thiol-epoxy ring opening of Enl was 
followed.  Enl55 (4.3 mg) and 1-thioglycerol (5 eq per Enl residue) were used to prepare the 
product, obtained as a white solid (6.0 mg, 75% yield).  1H NMR (400 MHz, D2O, 25 °C): δ 4.29-
3.91 (br m, 1H), 3.81-3.62 (br m, 2H), 3.62-3.51 (br m, 1H), 3.50-3.42 (m, 1H), 2.82-2.28 (br m, 
4H), 2.17-1.31 (br m 4H). 
 
CB-Enl55.  Enl55 (2.5 mg) and N,N-dimethyl-cysteamine-carboxybetaine (36 mg, 10 eq per Enl 
residue) were added to a 1 dram screwtop vial.  DI water (420 μL) was added and the reaction 
mixture was sonicated to give a fine suspension.  DBU was then added (40 μL, 10.5 eq) and the 
reaction was stirred vigorously for 48 hr to give a turbid solution, which was transferred to a 
2000 MWCO dialysis tube.  The reaction mixture was dialyzed against DI water for 2 days with 
2 water changes daily then lyophilized to dryness, yielding a white solid (5.6 mg, 97% yield).  1H 
NMR (400 MHz, 10% DCl in D2O, 25 °C): δ 2.60-2.21 (br m, 3H), 2.00-1.68 (br m, 3H), 1.46-
1.19 (br m, 6H), 1.12-0.95 (br m, 2H), 0.90-0.64 (br m, 2H), 0.02- -0.52 (br m, 4H). 
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(etEG2- Enl0.5-stat-mEG2- Enl0.5)55.  The general procedure for base-catalyzed thiol-epoxy ring 
opening of Enl was followed.  Enl55 (5.2 mg), 2-(2-ethoxyethoxy)ethane-1-thiol (2.5 eq per 
ENL), and 2-(2-methoxyethoxy)ethane-1-thiol (2.5 eq per Enl residue) were used to prepare the 
product, obtained as a white solid (8.8 mg, 80% yield).  1H NMR (400 MHz, D2O, 25 °C): δ 4.29-
3.86 (br m, 1H), 3.82-3.36 (br m, 8H), 3.26 (s, 1.5H), 2.83-2.42 (br m, 4H), 2.24-1.29 (br m, 4H), 
1.08 (t, J = 7.0, 1.5H). 
 
mEG2-EnlO55.  This compound was synthesized using a procedure for a related polypeptide.1  
mEG2-Enl55 (7.5 mg) and CSA (1.3 mg) were dissolved in DI water (0.88 mL).  An aqueous 
solution of TBHP (70 % (w/w), 16 eq per mEG2-Enl55 residue) was then added.  The reaction 
was let stir overnight.  The reaction mixture was then transferred to a 2000 MWCO dialysis bag 
and dialyzed against DI water for 48 hours with 2 water changes daily.  The dialyzed polymer 
was lyophilized to dryness to give the product as a white solid (6.6 mg, 83% yield).  1H NMR 
(400 MHz, D2O, 25 °C): 4.25-4.10 (br m, 1H), 4.06-3.95 (br m, 1H), 3.89-3.73 (br m, 2H), 3.64-
3.47 (br m, 4H), 3.26 (s, 3H), 3.20-2.77 (br m, 4H), 2.09-1.44 (br m, 4H). 
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etEG2-EnlO55.  This compound was synthesized using a procedure for a related polypeptide.1 
etEG2-Enl55 (7.4 mg) and CSA (1.2 mg) were dissolved in DI water (0.87 mL).  An aqueous 
solution of TBHP (70 % (w/w), 16 eq per etEG2-Enl55 residue) was then added.  The reaction 
was let stir 48 hr.  The reaction mixture was then transferred to a 2000 MWCO dialysis bag and 
dialyzed against DI water for 48 hours with 2 water changes daily.  The dialyzed polymer was 
lyophilized to dryness to give the product as a white solid (7.1 mg, 91% yield).  1H NMR (400 
MHz, D2O, 25 °C): 4.29-4.09 (br m, 1H), 4.07-3.95 (br m, 1H), 3.91-3.75 (br m, 2H), 3.65-3.52 
(br m, 4H), 3.48 (q, J = 7.1, 2H), 3.22-2.77 (br m, 4H), 2.01-1.48 (br m, 4H), 1.08 (t, J = 7.0, 3H). 
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